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ABSTRACT 
During my diploma thesis I focused on the expression of Notch signaling receptors and 
ligands in the human placenta and the role of the active Notch pathway in placental cell 
lines and primary cultures. Notch signaling is a highly conserved pathway that, dependent 
on the cellular context, can promote or suppress cell proliferation, cell death, acquisition 
of specific cell fates or activation of differentiation programs. Since gene chip analyses 
has revealed that several members of the Notch pathway are widely expressed in the 
human placenta I analysed mRNA expression of the four Notch receptors and five ligands 
in human gestational tissues and cells using semi-quantitative RT-PCR. To confirm these 
results, I performed immunohistochemical analyses focussing on first trimester tissue. 
These data revealed that all receptors and ligands are expressed in first trimester placenta, 
some of them being restricted to a subset of placenta cell populations. In order to study 
the activitiy of the Notch cascade I transiently transfected a trophoblastic cell line with 
luciferase vectors containing wilde type and mutated CBF1 binding sites revealing an 
endogenous Notch activity in this cell line. Additionally, I could further induce Notch 
activity by overexpressing the Notch intracellular domain. Using a co-culture model with 
the trophoblastic cell line and isolated primary decidual fibroblast I could show that the 
Notch pathway can be elucidated by the fibroblast cell population. In all transfection 
studies, the γ-secretase inhibitor DAPT was used to block the Notch pathway being a 
control for the endogenous and fibroblast-induced Notch activity. Finally, I could figure 
out that DAPT-induced blocking of the Notch pathway stimulates the migration not only 
of the trophoblastic cell line but also of villous explant culture-derived extravillous 
trophoblasts in a dose dependent manner. 
These data not only proved the presence of Notch receptors and ligands in the human 
placenta but also showed specific expression patterns suggesting some regulatory roles in 
trophoblast proliferation, cell column formation and invasion. The induction of 
trophoblast migration upon inhibition of Notch signaling further corroborates the 
influence of the Notch activity on trophoblast differentiation and invasion. Furthermore, 
the pathway has endogenous activity and can be induced by fibroblasts suggesting that 
Notch signaling could be an important communication tool between extravillous 
trophoblasts and decidual cells. Taken together, these data support the idea that the Notch 
signaling pathway might have a functional role during the development of the early 
human placenta. 
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ZUSAMMENFASSUNG 
Im Zuge meiner Diplomarbeit konzentrierte ich mich auf die Expression der Notch 
Rezeptoren und Liganden in der humanen Plazenta und auf die Rolle des aktiven Notch 
Signalweges in plazentären Zelllinien und primären Kulturen. Der Notch Signalweg ist 
ein hoch konservierter Mechanismus, der, je nach zellulärem Zusammenspiel, 
Zellwachstum, Zelltod, zelluläres Schicksal und Zelldifferenzierungen fördert oder 
hemmt. Aufgrund von genomischen Chip Daten, die das Vorhandensein vieler Faktoren 
des Notch Signalweges in der humanen Plazenta ergaben, begann ich mit der Detektion 
der mRNA der vier Notch Rezeptoren und den fünf Notch Liganden in humanen 
schwangerschafts-assoziierten Geweben und Zellen mit Hilfe der semi-quantitativen RT-
PCR. Um diese Ergebnisse zu bestätigen, führte ich immunhistochemische Analysen an 
Geweben des ersten Trimesters mittels validierten Antikörpern durch. Diese Daten 
ergaben, daß alle Rezeptoren und Liganden in der humanen Plazenta exprämiert werden, 
einige von ihnen auf ganz bestimmte plazentäre Zellpopulationen beschränkt. Um die 
Aktivität des Notch Signalweges nachzuweisen, transfizierte ich eine trophoblastäre 
Zelllinie mit Luziferase-Vektoren, die Wild-Typ und mutierte CBF1 Bindungsstellen 
trugen. Dies bestätigte eine endogene Notch Aktivität innerhalb dieser Zelllinie. 
Zusätzlich konnte ich die Notch Aktivität mithilfe der Überexpression der Notch 
Intrazellulären Domäne induzieren. Mithilfe eines Ko-Kultur Model Systems bestehend 
aus der trophoblastären Zelllinie und isolierten primären dezidualen Fibroblasten konnte 
ich zeigen, daß der Notch Signalweg auch durch die Fibroblasten aktiviert werden kann. 
In all den Transfektionsstudien verwendete ich den γ-Secretase Inhibitor DAPT um die 
Notch Signalkaskade zu blockieren, wodurch ich eine Kontrolle für die endogene und 
fibroblast-induzierte Notch Aktivität hatte. Schließlich fand ich heraus, daß das 
Blockieren der Notch Aktivität mittels DAPT, abhängig von der Dosierung, zu einer 
erhöhten Migration führt, und zwar nicht nur in der trophoblastären Zelllinie, sondern 
auch in extravillösen Trophoblasten aus villösen Explant Kulturen. 
Diese Ergebnisse haben nicht nur das Vorhandensein der Notch Rezeptoren und Liganden 
bewiesen, sondern zeigten auch spezifische Expressionsmuster wodurch der Schluß nahe 
liegt, daß diese eine regulierende Rolle in der Trophoblasten Proliferation, 
Zellsäulenformation und Invasion spielen. Die Erhöhung der Trophoblasten Migration 
aufgrund der Notch Signalweg Inhibierung bestätigt weiters den Einfluß der Notch 
Aktivität auf die Trophoblasten Differenzierung und Invasion. Weiters zeigt dieser 
Signalweg endogene Aktivität und kann durch Fibroblasten induziert werden, wodurch 
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der Schluß nahe liegt, daß der Notch Signalweg ein wichtiges Kommunikationswerkzeug 
zwischen extravillösen Trophoblasten und Deziduazellen darstellt. Zusammenfassend 
unterstützen diese Daten den Schluß, daß der Notch Signalweg eine funktionelle Rolle 
während der frühen Plazentaentwicklung spielen könnte. 
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1. Introduction 
1.1. The Human Placenta 
The human placenta develops from the trophectoderm of the blastocyst and is the 
connecting organ between mother and fetus. It supplies nutrient and oxygen to the fetus 
and passes out waste. Additionally, the human placenta produces hormones (e.g. human 
choriongonadotrophin, hCG) that are necessary for the maintenance of pregnancy. In the 
following chapter implantation, trophoblast differentiation and invasion will be described 
in detail. 
1.1.1. Implantation 
 
Fig. 1: Implantation of the blastocyst (Fitzgerald et al., 2008) 
(1) Blastocyst (BL) is formed of a trophectoderm surrounding the inner cell mass, both are covered by Zona 
pellucida (ZP), which is removed before implantation (2). Endometrium expresses LIF (leukemia inhibitory 
factor) that binds to the LIF receptor on the blastocyst (3). Next, the blastocyst attaches to the luminal 
epithelium (LE) of the uterine endometrium and secretes LIF by itself. At the same time, endometrial 
protein expression of gp130 and LIF receptor together with the appearance of pinopodes (P) increases (4). 
After the differentiation of the trophectoderm into inner cytotrophoblasts and syncytiotrophoblasts (ST), the 
latter invade into the maternal uterus (5). IL-1 secretion of the blastocyst stimulates glandular epithelia (GE) 
to produce LIF, which in turn assists for the complete implantation of the blastocyst (6). 
 
Implantation requires synchronous development of the blastocyst and endometrium. After 
fertilisation of the egg, the zygote develops from the two-cell state via the morula into the 
blastocyst that finally reaches the uterine endometrium. Supported by several soluble and 
membrane-bound proteins, the blastocyst adheres and invades into the endometrial wall. 
Among many influencing factors, LIF (leukaemia inhibitory factor), that is produced by 
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both the endometrium and the blastocyst, is found to be highly concentrated at the feto-
maternal interface thereby facilitating the implantation process (Kondera-Anasz et al., 
2004). A specialized cell population, the pinopodes that  protrude from the endometrium, 
are also discussed to assist in blastocyst adhesion (Bentin-Ley et al., 1999) and are found 
to be coexpressed with LIF (Aghajanova et al., 2003). Already in blastocyst state, the 
trophoblast cell population starts to produce the pregnancy specific hormone β-HCG 
(human chorionic gonadotrophin) that constrains the corpus luteum to maintain the 
production of progesterone. Progesterone suppresses the immune reaction at the foeto-
maternal interface thereby protecting the foetus from immune responses and rejections. 
1.1.2. The human mature placenta 
Maternal myometrium
Umbilical cord
Placental Villi
Maternal Decidua
Spiral 
Arteries
Intervillous 
Space
Chorionic plate
Basal plate
 
Fig. 2: Schematic illustration of the human adult placenta (SOMSO-Plast®, placenta-model, 
MS 47/16) 
The mature human placenta is the connecting and supplying organ between the mother and the fetus during 
pregnancy. It consists of a tree like structure (=placental villi) that emerges from the chorionic plate (facing 
the amniotic fluid) and is to some extent attached to the basal plate (facing the decidua of the maternal 
uterine wall). The villi, flooded with maternal blood (intervillous space) take up oxygen and nutrients and 
excrete fetal waste products back into the maternal circulation. The placenta is connected to the fetus via the 
umbilical cord that is the transferring organ between the fetus and the placenta.  
In Figure 2 the cross section of a human mature placenta is shown. This organ consists of 
the chorionic plate that faces the amniotic fluid, the basal plate which displays the 
connection area to the maternal uterine wall and the branching structure (placental villi) 
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that is flooded with maternal blood. The nutrients are delivered by the spiral arteries into 
the intervillous space where the uptake into the foetal system (villi) occurs. The transport 
goes on via the umbilical vessel system to the foetus. Waste products are conveyed back 
into the intervillous space and removed by the maternal vein system. 
1.1.3. Trophoblast differentiation and invasion 
VS
ST
CT
CC
EVT
GC
ET
SA
MD
IVS
 
Fig. 3: Trophoblast invasion 
In contrast to  floating villi (FV), anchoring villi (AV) are attached to the maternal decidua (MD). The 
villous stroma (VS) containing fetal blood vessels (V), fibroblasts, and other stromal cells, is surrounded by 
the basal membrane which provides the basis for the cytotrophoblasts (CT) and finally the 
syncytiotrophoblast (ST) layer that produces hormones and is primarily responsibly for transport functions. 
Cytotrophoblasts can proliferate to form cell column (CC), which attaches to the maternal decidua (the 
converted endometrium). The now called extravillous trophoblasts (EVTs) invade into the maternal decidua 
and first third of the myometrium to reach spiral arteries (SA), where they displace the endothelial cells 
(EC) and differentiate into endovascular trophoblasts (ET). Another population of EVTs arises by 
endoreduplication finally forming large, multinucleated giant cells (GC). IVS; intervillous space 
Figure 3 shows an enlargement of the villous structure at the feto-maternal interface of 
the first trimester of pregnancy. Basically, placental villi are divided into floating and 
anchoring villi; the latter mechanically support the attachment of the placenta to the 
uterine wall. The villous stroma with blood vessels, fibroblasts and other stromal cells is 
surrounded by a basal membrane that is coated with cytotrophoblasts (CTB). CTBs 
undergo two differentiation processes. On one hand, CTBs fuse to form a multinucleated 
cell layer, the syncytiotrophoblast layer (ST) that produces hormones and shields the villi 
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against the maternal blood. STs represent the transport unit of placental villi. On the other 
hand, CTBs proliferate and form cell columns. Their integrity might be maintained due to 
interaction of L-Selectin with carbohydrate ligands (Prakobphol et al., 2006). However, at 
their distal anchoring sites, CTBs detach from the columns and invade the maternal 
decidualized endometrium and inner myometrium, a process that is suggested to be 
initiated by extracellular matrix contact and decidual components. Additionally, oxygen 
concentrations might be critically involved since hypoxia promotes trophoblast 
proliferation whereas normoxia inhibits proliferation and induces migration (Genbacev et 
al., 1997). The now called extravillous trophoblast (EVT) has two further differentiation 
potentials. On one hand, EVTs are able to transform maternal spiral arteries into vessels 
of low resistance by replacing endothelial cells and mural vascular smooth muscle cells 
(Pijnenborg et al., 1983). Apoptosis of vascular smooth muscle cells around these vessels 
and displacement of maternal endothelial cells by endovascular trophoblasts (ET) thereby 
gaining endothelial-like functions expressing typical vascular adhesion molecules (Zhou 
et al., 1997) are key features of the particular invasive differentiation process (Harris et 
al., 2006; Pijnenborg et al., 1983). The second differentiation process of EVTs results in 
the generation of giant cells, large multinucleated cells whose functions still remain to be 
elucidated. 
In the last couple of years, two diverse theories concerning the progenitors of EVTs and 
syncytiotrophoblasts have emerged. The first theory indicates the presence of a 
bipotential trophoblast progenitor cell during the first trimester placenta. This cell is 
supposed to form either syncytiotrophoblast or EVT (Baczyk et al., 2006). The second 
theory is based on the presence of two separate villous cytotrophoblast populations being 
differently committed to produce either EVTs or syncytiotrophoblasts (James et al., 
2005). 
However, differentiation from CTB to EVT plays a critical role in developing vascular 
connection between the mother and the fetus. Additionally, the changes in the vessel 
conductivity are necessary to fulfill the embryo’s demands for nutrients and gases. 
Inadequate transformation of spiral arteries and shallow interstitial invasion were detected 
in the placental bed of women suffering from preeclampsia or severe intrauterine growth 
restriction (IUGR) (Fig. 1D) indicating that there is a defective EVT differentiation 
process in these pregnancies (Pijnenborg et al., 1991). Excessive invasion, on the other 
hand, is associated with partial and complete moles (Federschneider et al., 1980), and 
choriocarcinomas (Seckl et al., 2000; Shapter and McLellan, 2001). 
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The highly invasive behavior of EVTs in vivo and in vitro is a process that is very well 
observed in several types of cancer. Beside the investigation of pregnancy disorders, the 
trophoblast might also be a model to study a tumor-like behavior but displaying a strictly 
controlled invasion thereby gaining some insights into invasion processes and putative 
control mechanisms. 
 
 
Fig. 4: EVT invasion non-pregnant, pre-eclampsia/IUGR and normal pregnancy cases 
(Moffett-King, 2002) 
The invasive depth and spiral artery transformation in pregnancy disorders like pre-eclampsia and IUGR is 
reduced leading to inadequate nutrient and gas supply to the fetus. 
1.1.4. Differentiation markers of cytotrophoblasts and EVTs 
The following chapter shall give an overview of typical markers used in 
immunohistochemical analysis that allow distinguishing between different cell types and 
their differentiation levels. Fig. 4 represents immunohistochemistry performed of early, 
mid and late placenta. Cytokeratin 7 is used as a trophoblast marker while vimentin stains 
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stromal and decidual cells (data not shown). KI67 detects proliferative cells. For detection 
of fully differentiated EVTs, Kip2p57 staining is performed. Kip2p57 (cyclin-dependent 
kinase inhibitor) is a potential inhibitor of several G1 cyclin/Cdk complexes; 
overexpression of Kip2p57 arrests cells in G1 (Lee et al., 1995; Matsuoka et al., 1995; 
Seizinger, 1991). 
In early placenta, the villous trophoblast layer is a bilayer consisting of cytotrophoblasts 
and syncytium (Fig. 4, A). During onset of pregnancy, the cytotrophoblast layer 
disappears; only few cytotrophoblasts can by found in third trimester placenta (Fig.4, B). 
The cell column of early placentae is composed of proliferative cells (KI67) emerging 
from the villous tip and differentiated trophoblasts (Kip2p57) that form the distal part of 
the column. Note that some trophoblasts have overlapping expression (Fig. 4, C and D). 
In the midgestation placenta (22nd weak of gestation) villi have attached to the decidua 
and differentiated EVTs invade the maternal uterine layers (Fig. 4, E). EVTs displace 
endothelial cells of spiral arteries (Fig. 4, F) and a multi-nucleated  subpopulation (giants 
cells) can be found deep in the placenta bed (Fig. 4, G).  
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Fig. 5: Representative immunohistochemistry of human placental tissues 
Pictures A (400f magnification) and B (200f magnification) show villous parts of a 10weak and 39weak of 
gestation, respectively. Tissues are stained with cytokeratin 7 (trophoblast cells), Kip2p57 (differentiated 
cells) and DAPI (nuclei). Note that all cytotrophoblast nuclei of the late gestation are Kip2p57 positive 
whereas several CTBs of the early pregnancy are not fully differentiated. Panel C and D represent a cell 
column (10weak of gestation, 200f magnification) stained with KI67 (proliferation), Kip2p57 (C) and DAPI 
(nuclei) (D). Note the switch from proliferation to differentiation of trophoblasts along the cell column. 
Picture E shows staining of an anchored villus (22weak of gestation) with cytokeratin7 and Kip2p57. Note 
that the cell column trophoblasts are now mainly positive for Kip2p57. Picture F represents a decidual area 
with a spiral artery and surrounding EVTs. Note that endothelial cells are fully displaced by EVTs (positive 
for Cyto7). Picture G shows giant cells containing several nuclei positive for Kip2p57. Cytokeratin7 
negative cells in pictures F and G represent decidual cells.  
1.2. The Notch signalling pathway 
1.2.1. The canonical Notch signalling pathway 
Notch signalling is a highly conserved signalling pathway with different regulatory 
functions during development including lateral inhibition, boundary formation and cell 
fate assignation (Bray, 1998). The Notch pathway is a short-range communication 
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signalling event requiring cell-to-cell contact between a signal-sending cell carrying the 
ligand and a signal-receiving cell expressing the receptor. In mammals, genes encoding 
four Notch receptors (Notch 1-4) and five Notch ligands (Jagged1; Jagged2; Delta-like 
ligand 1, DLL1; Delta-like ligand 2, DLL2; Delta-like ligand 3, DLL3) are present 
allowing complex control and regulatory mechanisms (Fig. 2). In Drosophila, only one 
Notch receptor and the two different ligands, Delta and Serrate are expressed, while in C. 
elegans, two genes encode for Notch (lin-12 and glp-1) and several Delta/Serrate/Lag-2 
(DSL) homologues (Maine et al., 1995). The mammalian Notch receptors display both, 
redundant and unique features. Depending on the context, Notch signalling can promote 
or suppress cell proliferation, cell death, acquisition of specific cell fates or activation of 
differentiation programs (Kopan and Ilagan, 2009). The Notch signalling pathway has 
some unique features resulting finally into signal transduction. First, the receptor has to 
undergo some proteolytic events after ligand-receptor recognition to generate an active 
intracellular Notch fragment (NICD = Notch Intracellular Domain). Second, the Notch 
receptor displays both, the role of a membrane bound receptor and, in the form of the 
NICD, a transcriptional co-activator that translocates into the nucleus to transactivate the 
transcription of several target genes. Thus, this particular signalling pathway does not 
include any second messengers or signal amplification capacities. Hence, this signalling 
pathway is highly sensitive and operates with very little amounts of active signal 
transducers.  
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Fig. 6:The canonical Notch signalling pathway (Kopan and Ilagan, 2009) 
On its way to the cell surface, the Notch receptor gets fucosylated, glucosylated, cleaved at S1 by Furin-like 
convertases and the now fully mature receptor is anchored at the cell surface. After binding to a ligand, the 
receptor is cleaved at S2 by enzymes of the ADAM family creating the NEXT fragment (Notch 
extracellular truncation fragment), the perfect substrate for an enzyme complex called the γ-Secretase. This 
intramembrane cleaving protease cleaves at S3, resulting in the NICD (Notch intracellular domain) and at 
S4, which leads to the release of Nβ into the intercellular space. The NICD translocates into the nucleus and 
binds to the nuclear binding protein CSL [CBF1/RBPJk/Su(H)] thereby replacing Co-Repressors, recruiting 
MAM and Co-Activators which finally leads to the transcription of target genes including Hes and Hey. B: 
The arrows indicate the different cleavage positions and resulting products produced by the γ-Secretase. 
Cleavage at S3 can result in 4 different NICD products with different life spans according to the N-end rule. 
S4 cleavage releases two different Nβ fragments into the intercellular space 
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During each Notch receptor lifetime, several post-translational modifications and 
proteolytic events occur (Fig. 1A, 1B) (Bray, 2006). After translation the Notch receptors 
are fucosylated and glucosylated by the enzymes O-fut and Rumi. During the secretory 
pathway, the Notch polypeptide is cleaved by furin-like convertases within the secretory 
pathway at site 1 (S1) which is located within an unstructured loop of the 
heterodimerisation domain. This very first proteolytic event produces the mature Notch 
heterodimer (Notch extracellular domain – Notch transmembrane and intracellular 
domain) that is connected via non-covalent interactions. Cells that do express the 
glycosyltransferase Fringe can prolong the O-fucose thereby influencing the ligand 
specifity mediating the Notch Receptor activation. The Notch receptor is than anchored as 
a single-pass type I transmembrane protein (Fig. 2A, 2B) in the cytoplasm membrane. 
The binding of a ligand to the Notch Receptor leads to conformational changes of the 
cleavage site 2 (S2) being now accessible for an enzyme family called ADAM (a 
disintegrin and metalloprotease). Two members of this family are known to cleave at S2 
of the Notch receptors, ADAM10/Kuzbanian (Deuss et al., 2008) and ADAM17/TACE 
(tumour necrosis factor alpha converting enzyme), the particular ADAM required for the 
Notch Receptor activation is context dependent (Bozkulak and Weinmaster, 2009). The 
cleavage at S2 generates NEXT (Notch extracellular truncation fragment) which is a 
perfect substrate for another enzyme complex called γ--Secretase. This enzyme complex 
belongs to the growing family of intramembrane cleaving proteases (Selkoe and Wolfe, 
2007; Wolfe and Kopan, 2004). This protein complex that contains presenilin as the 
catalytic component (Kopan et al., 1996) cleaves NEXT (Fig. 1B) at site 3 (S3) and site 4 
(S4) either at the cell surface or in endosomal compartments, but it seems that the cell 
surface processing preferentially releases a more stable form of NICD. The γ--Secretase 
activity at S4 relieves the remaining Notch fragment (Nβ) into the intercellular space 
(Okochi et al., 2002) and the NICD into the cytoplasm by cleaving the NTMIC at S3. 
This cleavage is preferentially performed at valine 1744 (NICD-V) (Schroeter et al., 
1998), but recently, other cleavage product variants, NICD-L (lysine 1745 or 1746) and 
NICD-S (serine), have been identified (Fig. 6) (Tagami et al., 2008). According to the N-
end rule, the NICD-S and NICD-L are less stable and rapidly degraded by the 26S 
proteasome (Blat et al., 2002; Tagami et al., 2008). The NICD translocates into the 
nucleus and acts as a coactivator of the DNA-binding transcription factor suppressor of 
hairless Su(H) (CBF1/CSL/RBPJκ/Lag1) (Fortini and Artavanis-Tsakonas, 1994). In the 
absence of NICD, CBF1 is associated with co-repressor proteins and histone deacetylases 
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preventing transcription of the target genes. NICD binding leads to the co-repressors 
dissociation and recruitment of co-activators such as MAM1-3 and the MED8 mediator 
transcription activation complex (Kovall, 2008). This event upregulates gene expression 
of target genes such as the members of the bHLH repressor family ESR (Enhancer of 
Split Related), HES (Hairy and Enhancer of Split), or Hey (Hairy and Enhancer of Split 
Related) (Fischer and Gessler, 2003). Several proteins involved in the Notch signalling 
activity are listed in table 1. 
LHLMYVAAAAFVLLFFVGCTVLLS
S3
NICD-V
NICD-L+1
NICD-L+2
NICD-S
17471725
TMD
Nβ21 Nβ25
S4
 
Fig. 7: Proteolytic cleavage sites performed by γ--Secretase complex 
The γ-Secretase activity has two cleavage possibilities at S4 relieving Notch fragments (Nβ21, Νβ25) into 
the intercellular space. The cleavage at S3 can produce 4 different NICD fragments: The NICD-V (valine 
1744), which is the most stable one and additionally the product variants NICD-L (lysine 1745 or 1746) and 
NICD-S (serine) that are rapidly degraded 
Component class Drosophila Mammals Function 
Notch Receptors Notch Notch 1-4 Single transmembrane receptor 
and also transcription factor 
Ligands Delta, Serrate DLL1, DLL3-4, Jagged1 
and 2 
Single transmembrane ligands of 
the Notch receptor 
Nuclear Effectors Su(H) RBPJk/CBF1/CSL DNA binding transcription factor 
 Mastermind Mastermind1-3 Transcriptional Co-activator 
 Hairless, SMRTR Mint/Sharp/SPEN, 
NcoR/SMRT/Kyot2 
Transcriptional Co-repressors 
Canonical Target 
bHLH Repressor 
genes 
E(spl) HES/ESR/HEY Target genes of the Notch 
signalling pathways 
Table 1: proteins involved in the canonical Notch Signalling Pathway (Fiuza and Arias, 
2007; Kopan and Ilagan, 2009) 
Four Notch Receptors can bind to 5 different Notch ligands. Upon NICD translocation into the nucleus, it 
binds to RBPJk, replaces Co-Repressors, recruits Mastermind 1-3 and finally induces the transcription of 
target genes Hes, Hey, Esr (Hairy and Enhancer of Split, Hairy and Enhancer of Split Related, Enhancer of 
Split Related). 
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1.2.2. The CBF1 independent Notch signalling 
This particular signalling works without interaction with the nuclear binding protein 
CBF1. Shawber and colleagues have shown, that Notch signalling can inhibit muscle cell 
differentiation in a CBF1-independent manner. A truncated form of Notch lacking the 
CBF1-binding domain was still able to stop myoblast differentiation (Shawber et al., 
1996). Studies in drosophila finally revealed two kinds of alleles of Notch, both mutants 
with gain of function phenotypes independent of Su(H). Abruptex (Ax; point mutants 
concerning the EGF-like repeats 24-29) and Microchaetae defective (Mcd; deletions of 
protein domains C-terminal to the ANK repeats) depend on shaggy, that encodes the 
Drosophila homologue of GSK3β and plays a role in the Wnt pathway (Brennan et al., 
1997). Further studies in drosophila confirmed a cross link between Notch activity and 
the Wnt pathway indicating that Notch influences Wnt signalling by setting a threshold 
for the function of β-Catenin (Hayward et al., 2005). In vertebrates, two groups could 
show a direct effect of Notch on the β-Catenin activity, thereby acting as a tumour 
suppressor or influencing cell fate decisions (Deregowski et al., 2006; Nicolas et al., 
2003). 
1.2.3. Structure of the Notch Receptors and Notch Ligands 
1.2.3.1. Structure of the Notch Receptor 
NECD NTMIC
EGF repeats (1-36)
LNR
TMD
RAM
NRR
HD ANK
NLS
PEST
 
Fig. 8: Structure of the mammalian Notch Receptor 1 
The Notch Extra-Cellular Domain (NECD) consists of 1-36 EGF repeats important for ligand interactions 
and the Negative Regulatory Region (NRR) which is formed by three cysteine-rich Lin12-Notch repeats 
(LNR) and a heterodimerisation domain (HD). The NRR hides the site 2 cleavage site until a ligand binds to 
the receptor somehow provoking the accessibility of ADAM to S2. Several domains are located on the 
Notch Trans-Membrane Intracellular domain. The transmembrane domain (TMD) harboring the cleavage 
sites S3 and S4 is followed by the RBPJk-association module (RAM) and an ANK domain, which is 
surrounded by nuclear location sequences. Finally, there is a region called PEST (proline, glutamic acid, 
serine, threonin), which is important for NICD degradation after the signal activity to ensure low levels of 
NICD present in the cell thereby raising the sensitivity to Notch response.  
 Introduction 
 
 13 
The mature Notch Receptor is a heterodimer consisting of a Notch extracellular domain 
(NECD) and a Notch trans-membrane intracellular domain (NTMIC). NECD: The 
extracellular domain mainly consists of up to 36 epidermal growth factor (EGF) repeats 
that are involved in ligand interactions. The EGF repeats 11 and 12 are responsible for 
trans-interactions (de Celis and Bray, 2000) with the ligands of signal sending cells while 
the EGF repeats 24-29 mediate the cis-inhibition that prevents the auto-activation 
performed by ligands of the same cell (Glittenberg et al., 2006). The ability of EGF 
repeats to bind calcium ions influence the Notch structure and affinity to ligands (Cordle 
et al., 2008) and may affect the signalling performance (Raya et al., 2004). The next 
region on the extracellular domain is the Negative Regulatory Region (NRR) which is 
composed of three cysteine-rich Lin12-Notch repeats (LNR) and a heterodimerisation 
domain (HD). The NRR deeply buries the ADAM cleavage site S2 (located 12 amino 
acids before the transmembrane domain) until a ligand is bound to the receptor. This 
region displays a structural regulation mechanism preventing auto-activation of the 
receptor in the absence of a ligand. There are some theories how the accessibility to S2 
can be gained upon ligand binding and several mechanisms that regulate the closed and 
open state of this cleavage site are discussed. Conformational changes due to the 
interaction with the ligand (Gordon et al., 2007) or a mechanical force pulling the 
receptor in ligand direction due to ligand-NICD transendocytosis performed by the signal 
sending cell (mechanotransduction model) (Parks et al., 2000). NTMIC: The 
transmembrane domain of the Notch receptor ends with 3-4 arginine/lysine residues. This 
is followed by 12-20 amino acids centred on a conserved WxP motif, which represents 
the RBPJk-Association-Module (RAM).  Nuclear location sequences embrace an ANK 
domain (seven ankyrin repeats). The last structure of the C-terminal end of NTMIC is 
formed by conserved proline/glutamic acid/serine/threonin-rich motifs that harbour 
degradation signals (degrons). 
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1.2.3.2. Structure of the Notch Ligands 
DLL3
DLL4
DSL/EGF ligands
DLL1
Jagged1
Jagged2
DOS
TMDDSL
C-rich domain
DSL/DOS/EGF ligands
A B
 
Fig. 9: Structure of mammalian Notch Ligands 
The mammalian Notch ligands can be divided into ligands containing Delta/Serrate/LAG-2 (DSL); Delta 
and OSM-11-like (DOS) and endothelial growth factor EGF repeats which are called Jagged1, Jagged2 and 
DLL1 (Delta like ligand 1). DLL3 and DLL4 lack the DOS domain and belong to the DSL/EGF ligand 
group. 
Reviewed by D’Souza and colleagues, most notch ligands are type I transmembrane 
proteins (D'Souza et al., 2008). The largest family of Notch ligands contains three related 
structural motifs including the N-terminal DSL (Delta/Serrate/LAG-2) motif, tandem 
EGF repeats called the DOS domain (Delta and OSM-11-like proteins) (Komatsu et al., 
2008) and EGF-like repeats (Fig. 8). DSL ligands are split into cysteine-rich domain 
containing (Jagged-1, Jagged-2, DLL-1) and cysteine-rich domain lacking (DLL-3, DLL-
4) ligands. Ligands without DOS and DSL domains are considered to act in the non-
canonical Notch signalling pathway (Takahashi et al., 2008). 
1.2.4. Functions of Notch 
Notch function and control mechanisms was recently reviewed by Borggreve and Oswald 
(Borggrefe and Oswald, 2009). In general, Notch signalling is important for binary cell 
fate decisions during development (lateral inhibition and induction) and differentiation 
processes (stem cell maintenance and induction of terminal differentiation). Examples for 
Notch signalling in differentiation processes are given by the human intestine and skin. 
Notch signalling is known to sustain an undifferentiated state of crypt progenitor cells in 
the intestine (Stanger et al., 2005). In human skin Notch signalling induces cell cycle 
arrest in keratinocytes which enforces differentiation of keratinocytes (Okuyama et al., 
2008). 
 Introduction 
 
 15 
1.2.4.1. Functions of Notch target genes 
Several studies in mammals have revealed that the transcriptions factors of the Hes and 
Hey family are the best-described Notch target genes. Hes and Hey proteins are helix-
loop-helix transcriptions factors that mainly act as functional repressors (Davis and 
Turner, 2001). The investigation of Hes and Hey gene deficient mice have revealed 
different functions of Hes and Hey proteins during development (reviewed by Andreas 
Fischer and Manfred Gessler) (Fischer and Gessler, 2007). In general, Hes proteins play 
important roles in development of the nervous system, pancreas, endocrine cells and 
lymphocytes while Hey proteins critically influence the cardiovascular system. A 
summary of several Hes and Hey target genes is also listed in the review Andreas Fischer 
and Manfred Gessler. With respect to placental gene expression some findings were 
interesting. In pancreatic progenitor cells Hes1 inactivation resulted in the upregulation of 
p57Kip2 expression leading to cell cycle arrest, precocious differentiation and depletion of 
the progenitor pool (Georgia et al., 2006). Additionally, Murata et al could show that 
Hes1 controlled proliferation through the transcriptional repression of the p27Kip1 and 
Hes1 -/- mice had increased levels of this particular cdk inhibitor (Murata et al., 2005). In 
fibroblasts, inhibition of Hes1 caused a higher susceptibility of these cells entering a 
senescence and terminal differentiated state (Sang and Coller, 2009). Considering these 
results, Hes1 seems to influence the proliferation and differentiation of distinct cell 
populations. However, p57Kip2 is highly expressed in differentiated, non-proliferative 
EVTs and CTBs and its expression could be under the control of the Notch target Hes1. 
1.2.5. Notch and human Pathologies 
Since the Notch signalling pathway plays a critical role in many fundamental processes, it 
is not surprising that aberrant gain or loss of notch signalling components lead to multiple 
human disorders. Basically, these mutations cause developmental syndromes, adult-onset 
diseases and cancer. 
Developmental syndromes: Mutations in both, the Jagged1 gene (Li et al., 1997; Oda et 
al., 1997) and the Notch-2 gene (Samejima et al., 2007) are associated with the Alagill 
syndrome. Normally, it is diagnosed in the first 2 years and has multiple defects, thereby 
affecting kidney, heart, skeleton, liver and eye. Another disease caused by a missense 
mutation (G274D) in Jagged-1 is the Tetralogy of Fallot, whose clinical signs are four 
heart malformations (Eldadah et al., 2001). Mutations in DLL3 lead to spondylocostal 
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dysostosis, where vertebral segmentation defects are associated with rib anomalies 
(Gridley, 2003). Mutations in Notch-1 cause the familial aortic valve disease, which is 
accompanied with a spectrum of developmental aortic valve anomalies and severe valve 
calcification (Garg et al., 2005). 
Adult-onset disease: CADASIL (cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy), an autosomal-dominant vascular disorder, 
is caused by mutations of Notch3 gene (Gridley, 2003). In CADASIL patients, a 
degeneration and loss of vascular smooth muscle cells can be observed leading to a 
variety of symptoms, including recurrent subcortical ischemic strokes, progressive 
cognitive decline, dementia and premature death (Chabriat et al., 1995; Ruchoux et al., 
1995). 
1.2.5.1. Notch and Cancer 
Notch deregulations due to mutations in the Notch heterodimerisation domain or the 
PEST domain cause T-cell acute lymphoblastic leukaemia (Weng et al., 2004). Finally, 
inhibition of the Notch signaling in certain tumours had effects on tumour growth and 
differentiation:  Inhibition of the Notch signaling pathway turned proliferative crypt cells 
into goblet cells indicating that colon adenomas might need the concerted activity of the 
Notch signaling pathway (van Es et al., 2005). Ridgway and colleagues found out, that 
the blocking of the Notch pathway by neutralizing DLL4 stopped tumour growth via 
deregulated angiogenesis (Ridgway et al., 2006). 
 
Nicholas and colleagues found out that Notch1 deficiency in skin and primary 
keratinocytes caused the development of basal-cell carcinoma-like tumours. Furthermore, 
they could observe that Notch1 was able to inhibit β-Catenin-mediated signaling 
suggesting that Notch1 may function as a tumour suppressor gene in mammalian skin 
(Nicolas et al., 2003). In one form of lung cell cancer, the small cell lung cancer (SCLC), 
the constitutively active Notch signaling caused a growth arrest associated with the up-
regulation of p21waf1/cip1 and p27kip1 supporting the idea that Notch activation can be 
associated with a reduction in neoplastic potential (Sriuranpong et al., 2001). 
 
In another study performed by Li and colleagues, the authors found out that the Notch 
ligand DLL4 acts as a positive driver for tumour growth in human glioblastoma and 
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prostate cancer. They showed an up-regulation of DLL4 in tumour cells and tumour 
endothelial cells of human glioblastoma. DLL4 elevation in the tumour cells induced 
Notch signaling in the stromal/endothelial cells thereby increasing the blood vessel size 
and the vascular function within tumours. This finally leads to the promotion of tumour 
growth which was, to some extent, caused by the reduction of tumour hypoxia and 
apoptosis (Li et al., 2007). 
 
Another study investigating meningiomas found out that increased Notch1 and Notch2 
signaling correlates with the tetraploidy in meningiomas thereby leading to chromosomal 
instability suggesting that abnormal Notch signaling may promote tumour development 
(Baia et al., 2008). A further study supporting the idea of Notch being a tumour-
promoting factor was performed by Pannequin and colleagues. Using a colorectal cancer 
cell line, a mouse model and the human colorectal cancer samples they could show a 
correlation between Notch pathway inhibition and increased goblet cell differentiation. 
Furthermore, the authors found out, that the Notch ligand Jagged-1 was under the control 
of β-catenin/TCF-4 indicating a cross talk between the two pathways thereby promoting 
cancer progression (Pannequin et al., 2009). Taken together, the Notch signaling pathway 
seems to have a pivotal role: it can act as tumour suppressor as well as a tumour promoter 
depending on the different expression pattern, the cellular context and the potential to 
interfere with other signaling pathways, e.g. the Wnt-signaling cascade 
1.2.6. The role of Notch signaling in the placenta 
Components of the Notch pathway are widely expressed in the mouse placenta and were 
shown to be critically involved in murine placental development. In particular, 
homozygous mutation of Notch receptor 1, DLL4, Hey1/Hey2 and CBF1 resulted in the 
inhibition of chorioallantoic branching (Gasperowicz and Otto, 2008). Mutations in the 
ankyrin repeat of the Notch receptor 2 lead to malformation of maternal blood sinuses in 
the developing mouse placenta (Hamada et al., 2007) while Notch3 does not seem to be 
essential for embryonic development or fertility in mice (Krebs et al., 2003). The 
distribution of Notch proteins and their ligands was also analyzed in normal and 
preeclamptic human placentas (Cobellis et al., 2007; De Falco et al., 2007). 
Immunohistochemical analysis was performed detecting Notch receptor 1, 4 and Jagged1 
in CTB, ST and EVT. In preeclamptic villi, those Notch isoforms were decreased 
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suggesting a malfunction of the Notch signaling pathway in placental development and 
angiogenesis. Similar findings were observed by Sahin and colleagues investigating the 
placentae of pregnancies with intrauterine growth restriction (IUGR) or pregnancy 
induced hypertension (PIH). Furthermore the expression of several Notch isoforms and 
functionality of the Notch signaling pathway was detectable in the endometrium and 
endometrial stromal cells (Cobellis et al., 2008; Mazella et al., 2008; Mikhailik et al., 
2009). 
 Goal of the Study 
 
 19 
2. Goal of the Study 
The Notch pathway seems to play many roles in different types of cells and tissues 
dependent on the developmental state and cellular context. Additionally, several diseases 
including the influence of cancer formation and progression are provoked by deregulation 
of the Notch pathway. The placenta is an organ that develops rapidly thereby undergoing 
several differentiation and invasion processes that are strictly regulated in a time- and 
dose-dependent manner. The interplay of the differently skilled trophoblasts with other 
cell types found in pregnancy tissues are of crucial importance to provide an 
uncomplicated pregnancy including the optimal supply of the fetus with nutrients and 
gases. However, gene chip analysis data revealed, that several mRNAs of the Notch 
receptors and ligands are expressed in different human placental cell types. This 
occurrence supports the idea that the Notch signaling might play a role within some of the 
differentiation and invasion processes in the human placenta. 
According to this, the compilation of the expression profile of all Notch receptors and 
ligands in the human placenta will be first determined. The exact expression of receptors 
and ligands are supposed to give some insights into the potential interaction of different 
cell populations or developmental control mechanisms. Since p57Kip2 seems to be 
regulated by Notch signaling in several human cell types, co-expression of Notch 
members with proliferation or differentiation markers will be determined. Furthermore, 
the activity of the Notch pathway will be demonstrated using the trophoblastic cell line 
SGHPL-5 to ensure that the present Notch members are not only expressed but can also 
elicit the Notch pathway. Stimuli with the active Notch intracellular domain and the 
activation with a different cell line that provides a ligand-dependent activation will be 
performed. Additionally, the functional influence of the Notch cascade activity on the 
trophoblast migratory potential will be tested. Finally, a co-culture model using villous 
explants and first trimester primary decidual cells will be tested for the communication of 
different cell types with each other. 
Taken together, Notch signaling might have some putative roles in the human placenta. It 
could be involved in the decision of CTBs forming either syncytiotrophoblasts or EVTs. 
Furthermore, this signaling pathway might control the switch of proliferation and 
invasion in cell columns. Additionally, the interaction of decidual cells with EVTs could 
influence the invasive depth of trophoblasts. Using the experiments described above I will 
try to gain more insights into the importance of Notch signaling in the human placenta. 
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3. Results 
3.1. Expression of Notch receptors and ligands 
3.1.1. mRNA expression of Notch receptors and ligands 
 
Fig. 10: mRNA detection of Notch family members using semiquantitative RT-PCR 
Several cDNAs of different trophoblast and fibroblast subpopulations of first and third trimester placentae 
were used in RT-PCR detecting Notch receptors and ligands. The primer sequences, cycle numbers and 
annealing temperatures are listed in table 2; the fragment sizes are indicated. 
In the first experiments I used RT-PCR for the detection of all Notch pathway receptors 
and ligands to determine the mRNA expression of the Notch family members throughout 
pregnancy. In Figure 10 the whole table of the PCR results is shown. The Notch receptor 
1 seems to be predominantly expressed in the cytotrophoblasts of first and third trimester 
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pregnancy while it is weaker in all other cell or tissue preparations. Similar results could 
be obtained for the Notch receptor 2, which was also strongly expressed in the 
trophoblastic cell line SGHPL-5. Notch-3 could only be detected in the first and third 
trimester cytotrophoblasts. Notch-4 receptor showed expression in the tissue preparations 
of the first and third trimester. DLL-1 was not strongly expressed but showed a weak 
staining in trophoblast and fibroblast cells. DLL-3 showed mRNA expression only in 
third trimester trophoblasts and SGH-PL5. The Jagged-1 ligand could be detected in all 
cDNAs except the decidual fibroblasts. Interestingly, it was the only ligand that was also 
expressed in syncytialized trophoblasts. Jagged-2 was expressed in cytotrophoblasts of 
the first and third trimester, the tissue preparations and clearly in extravillous 
trophoblasts, where the expression of the small fragment (the second splice variant) was 
stronger expressed than in other cell populations tested. Expression of Glycerinaldehyd-3-
phosphat-Dehydrogenase (GapDH) was used as a loading control. 
 
All following experiments are performed with cell and tissue preparations of the first 
trimester of pregnancy to focus on trophoblast differentiation and invasion. 
3.1.2. Protein expression of Notch receptors and ligands  
For the detection of protein expression and localisation of the Notch receptors and ligands 
I performed immunohistochemistry of first trimester placenta. Beside the particular 
receptor and ligand antibodies I additionally used specific antibodies to detect 
trophoblasts (cytokeratin7), stromal cells (vimentin), proliferative cells (KI67) and 
differentiated cells (p57Kip2) for tissue orientation (cytokeratin7, vimentin) and EVT 
differentiation (Ki67, p57Kip2). All pictures display representative areas and photographs 
are taken at 400-fold magnification. The used primary and secondary antibodies, 
dilutions, species and providing companies are listed in table 5 and 6 (materials and 
methods). 
 
 Results 
 
 23 
Cyto7
DAPI
DAPI
Notch-1 DAPI
KI67/p57
Cyto7/Vim
KI67
cts vs
cc
evt
ct
s
vs
cc
evt
cts vs
cc
evt
cts vs
cc
evt
cts vs
cc
evt
cts vs
cc
evt
cts vs
cc
evt
cts vs
cc
evt
Notch-1/DAPI
ct
s
vs
cc
evt
 
Fig. 11: Notch-1 expression in cell columns of 1st trimester placentae 
Staining of Notch-1 (upper panel from right to left) with the corresponding nuclei staining and the overlay 
picture. Note that the proximal cell column trophoblasts express Notch-1 without any correlation of the 
receptor expression with proliferation and differentiation. The picture series in the middle (from right to 
left) shows the detection of cytokeratin 7 with the corresponding nuclei staining and an overlay picture with 
cytokeratin7 (green) and vimentin (red). Staining of KI67 is shown in the lower panel with the 
corresponding nuclei staining and a costaining with KI67 (green) and detection of p57Kip2 (red). s, 
syncytiotrophoblast; vs, villous stroma; cc, cell column; evt, extravillous trophoblast 
Notch receptor 1: The Notch receptor 1 stained the cytoplasmic membranes and was 
predominantly expressed in trophoblasts of the proximal cell column and the cells of the 
villous stroma (Fig. 11). Regarding Notch-1 positive trophoblasts, the staining started at 
the apical surface of first row of cell column trophoblasts and was not present luminal to 
the villous stroma. After two to four rows of Notch-1 positive cell column trophoblasts, 
the detection vanished abruptly even before the differentiation of the trophoblasts to the 
invasive phenotype has been completed. Regarding the proliferative area of the cell 
column, the expression of Notch-1 does not seem to correlate with the cell cycle.  There is 
no staining visible in other trophoblast subpopulations or cells that are associated with 
vessel formation, including endothelial cells and smooth muscle cells (Fig.12).  
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Fig. 12: Notch-1 expression of floating villi of 1st trimester placentae 
Staining of Notch-1 (upper panel, from right to left) is shown with the corresponding nuclei staining and the 
overlay picture. Detection of cytokeratin 7 (lower panel) with the corresponding nuclei staining and an 
overlay picture with cytokeratin7 (green) and vimentin (red) is shown. Note that villous stromal cells, but 
not vessels and surrounding muscle cells, strongly express Notch-1; ct, cytotrophoblast; s, 
syncytiotrophoblast; vs, villous stroma; v, vessel 
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Fig. 13: Notch-2 expression of cell columns of 1st trimester placentae 
Staining of Notch-2 (upper panel) is shown with the corresponding nuclei staining. Note, that all placental 
cell types express Notch-2. The middle panel shows detection of cytokeratin 7 (middle panel) with the 
corresponding nuclei staining and an overlay picture with cytokeratin7 (green) and vimentin (red). KI67 
staining is shown in the lower panel with the corresponding nuclei and a costaining with KI67 (green) and 
p57Kip2 (red). ct, cytotrophoblast; s, syncytiotrophoblast; vs, villous stroma; cc, cell column; evt, 
extravillous trophoblast; 
Notch Receptor 2: The Notch receptor 2 was expressed in nearly all cells of the placenta 
including syncytiotrophoblasts, cytotrophoblasts and villous stroma cells (Fig. 13). The 
staining pattern changed along the cell column from a uniform staining of the cytoplasmic 
membranes (proximal cell column) to a patchier staining (distal cell column).  
 
Notch Receptor 3: This receptor could be detected in cytoplasmic membranes of 
cytotrophoblasts, trophoblasts of the proximal part of the cell column and villous stromal 
cells (Fig. 14). The antibody also strongly reacted with endothelial cells of the villous 
stroma and foetal blood cells. Compared to Notch1 expression, the cell column 
expression of Notch3 was even more distal but still vanished within the proliferative cell 
population and was absent from EVT proliferation.  
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Fig. 14: Notch-3 expression in cell columns and floating villi of 1st trimester placentae 
Panels one to three represent sections of a cell column; the last two panels show a floating villus. Staining 
of Notch-3 are shown in the first and forth panel with the corresponding nuclei staining and overlays (from 
right to left). Note, that Notch-3 is expressed in villous cytotrophoblasts, proximal cell column trophoblasts, 
stromal cells and stromal vessel. Cytokeratin 7 expression with the corresponding nuclei staining and 
overlay pictures with cytokeratin7 (green) and vimentin (red) are shown in the second and last panel. 
Detection of KI67 with the corresponding nuclei staining and a costaining with KI67 (green) and p57Kip2 
(red) are shown in the middle panel. ct, cytotrophoblast; s, syncytiotrophoblast; vs, villous stroma; cc, cell 
column; evt, extravillous trophoblast; v, vessel 
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Fig. 15: Notch-4 expression in floating villi of 1st trimester placentae 
Staining of Notch-4 (green) is show in the upper panel with the corresponding nuclei staining and the 
overlay picture. Note that Notch4 is strongly expressed in stromal vessels and endothelial cells and very 
weakly in cytotrophoblasts. The lower picture series shows detection of cytokeratin 7 with the 
corresponding nuclei staining and an overlay picture with cytokeratin7 (green) and vimentin (red). ct, 
cytotrophoblast; s, syncytiotrophoblast; vs, villous stroma; v, vessel 
Notch Receptor 4: The Notch receptor 4 was very weakly expressed in villous 
cytotrophoblasts and strongly stained the villous endothelial cells and foetal blood cells 
(Fig. 15).  
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Fig. 16: Jagged-1 expression in cell columns of 1st trimester placentae 
Staining of Jagged-1 (upper panel) is shown with the corresponding nuclei staining and the overlay picture. 
Note that Jagged-1 in expressed in cytotrophoblasts, proximal cell column trophoblasts and villous stromal 
cells. The middle panel represents detection of cytokeratin 7 (middle panel) with the corresponding nuclei 
staining and an overlay picture with cytokeratin7 (green) and vimentin (red). Staining of KI67 is shown in 
the lower panel with the corresponding nuclei staining and a costaining with KI67 (green) and detection of 
Kip2p57 (red). ct, cytotrophoblast; s, syncytiotrophoblast; vs, villous stroma; cc, cell column; evt, 
extravillous trophoblast 
Jagged-1: The antibody against Jagged-1 detected the villous stromal cells, 
cytotrophoblasts, proximal cell column trophoblasts and, similar to Notch1 and Notch3, 
disappeared in distal cell column trophoblasts (Fig. 16). Once again, the loss of Jagged-1 
did not correlate with the cell cycle of the cell column trophoblasts. Interestingly, Jagged- 
1 could also be detected in the apical surface of selected syncytial parts and seems to be 
associated with contact points of distinct syncytial membranes. Fig. 17 shows different 
regions of the placenta highlighting the areas of interest with red arrows.  
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Fig. 17: Jagged-1 expression in syncytia of 1st trimester placentae 
The upper and lower panel (from right to left) shows staining of Jagged-1 with the corresponding nuclei 
staining (DAPI) and the overlay pictures. Note that the contact areas of syncytia strongly express Jagged-1 
(red arrows). The middle panel represents the staining with cytokeratin 7, DAPI and vimentin 
corresponding to the first row of pictures. ct, cytotrophoblast; s, syncytiotrophoblast; vs, villous stroma; cc, 
cell column; evt, extravillous trophoblast 
Jagged-2: Jagged-2 was expressed in villous stromal cells, cytotrophoblasts, proximal cell 
column trophoblasts and distal extravillous trophoblasts (Fig. 18). Similar to the 
expression of Notch-2, this particular ligand had a different, more patchy staining pattern 
in distal EVTs with a strong perinuclear expression (highlighted with red arrows) 
compared to the expression profile in the other trophoblasts and stromal cell populations. 
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Fig. 18: Jagged-2 expression in cell columns and EVT-areas of 1st trimester placentae 
The first three rows show a cell column stained with Jagged-2 and the corresponding expression profiles 
with Cytokeratin7/Vimentin and KI67/p57Kip2. Note, that Jagged-2 was expressed in cytotrophoblasts, 
proximal cell column trophoblasts and villous stromal cells. The last two rows of pictures represent Jagged-
2 and the corresponding cytokeratin expression in distal EVT areas, respectively. Note, that the receptor 
showed a patchy expression with perinuclear enrichment (red arrows). ct, cytotrophoblast; s, syncytium; vs, 
villous stroma; cc, cell column; evt, extravillous trophoblast 
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Fig. 19: DLL-1 expression in cell columns of 1st trimester placentae 
The upper panel (from right to left) shows staining of DLL-1 with the nuclei staining (DAPI) and the 
overlay pictures. Note that DLL-1 was expressed in all placental cell types. The middle panel represents the 
corresponding staining with cytokeratin 7, DAPI and vimentin. The last row of pictures represents 
proliferation (KI67) and differentiation (p57Kip2) of this cell column. ct, cytotrophoblast; s, 
syncytiotrophoblast; vs, villous stroma; cc, cell column; evt, extravillous trophoblast 
DLL-1: The antibody against DLL-1 showed continuously staining throughout the first 
trimester placenta, including the syncytiotrophoblasts and seems not to be regulated by 
proliferation or differentiation of trophoblasts (Fig. 19). 
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Fig. 20: DLL-3 expression in cell columns of 1st trimester placentae 
The upper panel (from right to left) shows staining of DLL-3 with the nuclei staining (DAPI) and the 
overlay pictures. Note that DLL-3 was expressed in distal cell column trophoblasts. The middle panel 
represents the corresponding staining with cytokeratin 7, DAPI and vimentin. The last row of pictures 
represents proliferation (KI67) and differentiation (p57Kip2) of this cell column. ct, cytotrophoblast; s, 
syncytiotrophoblast; vs, villous stroma; cc, cell column; evt, extravillous trophoblast 
DLL-3: DLL-3 was expressed at the apical surface of the syncytiotrophoblasts and in 
distal EVTs (Fig. 20). The expression of this ligand shows a correlation with the exit of 
the cell cycle in extravillous trophoblasts since the expression starts in those EVTs that 
express p57Kip2 and have widely lost their proliferative potential. 
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Fig. 21: DLL-4 expression in cell columns of 1st trimester placentae 
The upper panel (from right to left) shows staining of DLL-4 with the nuclei staining (DAPI) and the 
overlay pictures. Note that DLL-4 is expressed in villous stromal cells, cytotrophoblasts and proximal cell 
column trophoblasts. The middle panel represents the corresponding staining with cytokeratin 7, DAPI and 
vimentin. The last row of pictures represents proliferation (KI67) and differentiation (p57Kip2) of this cell 
column. ct, cytotrophoblast; s, syncytiotrophoblast; vs, villous stroma; cc, cell column; evt, extravillous 
trophoblast 
DLL-4: The staining pattern of DLL-4 had similarities to the expression profile of the 
Notch receptor 3. The ligand was expressed in villous stromal cells, cytotrophoblasts and 
proximal EVTs (Fig. 21). The expression vanished with the distance to the villous along 
the cell column. Once again, the expression was not associated with the 
proliferation/differentiation of the extravillous trophoblasts.  
3.2.  Notch pathway activity 
In this chapter, I transiently transfected the first trimester trophoblastic cell line SGHPL-5 
with reporter plasmids (4mtCBF1Luc, 4wtCBF1Luc) to measure the Notch signaling 
activity. Furthermore, I used an eukaryotic expression plasmid carrying the functional 
part of the Notch receptor 1 intracellular domain (NICD) to overexpress this particular 
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NICD thereby stimulating the Notch pathway. All three plasmids were kindly provided by 
Diane Haywarth (University of Otago, New Zealand). In order to obtain a mock control 
for the NICD overexpression, I removed the NICD fragment using the restriction 
endonucleases EcoR1 and XbaI. Graphs and descriptions of the used plasmids are shown 
in materials and methods. All experiments were repeated at least three times. 
3.2.1. Notch pathway activity among the SGHPL-5 trophoblastic cell 
line 
To assess the Notch signaling activity I transiently transfected the trophoblastic cell line 
SGHPL-5 with a reporter construct containing 4 CBF1 binding sites upstream of the 
luciferase gene (4xwtCBFLuc) (Fig. 22). A plasmid with mutations in the CBF1 binding 
sites (4xmtCBFLuc) displayed the background level and the plasmid pSG5-Flag-NICD 
that overexpresses the Notch receptor 1 intracellular domain (NICD) was used to activate 
the Notch signaling pathway. The white bars represent the cells that were transfected with 
the vector containing the mutated CBF1 binding site displaying the threshold level of the 
transfection experiments. The upregulation of the luciferase activity with the wild type 
CBF1 reporter construct (black bars) was doubled compared to the mutant control 
plasmid thereby indicating an ongoing Notch activity among SGHPL-5 cells without any 
stimulation. Blocking of the γ-Secretase activity (with 10µM DAPT) had no effect on the 
mutant CBF1 reporter plasmid. In the wild type studies, the Notch activity could be 
reduced significantly in the presence of DAPT additionally confirming the endogenous 
Notch activity of the trophoblastic cell line. Overexpression of the NICD domain strongly 
upregulates luciferase activity indicating a high induceability of the Notch cascade in the 
trophoblastic cell line. Take together, the transfection of the 4wtCBFLuc indicates that 
there is a Notch cascade activity among SGHPL-5 cells. Overexpression of the NICD 
domain in combination with the wild type CBF1 reporter plasmid further increased the 
Notch cascade activity.  
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Fig. 22: Notch pathway activity among the trophoblastic cell line SGHPL-5 
Transient transfection with the 4wtCBFLuc (black bars) without any stimulation show a two-fold induction 
compared to the 4xmtCBFLuc (white bars). Treatment with 10µM DAPT reduces the Notch activity and 
overexpression of the NICD domain strongly upregulates the luciferase activity. Mean values ± SD of four 
experiments performed in duplicates are shown. Normalized value of unstimulated control (4xmtCBFLuc) 
was arbitrarily set at 100%. *, P < 0.05 
To control the overexpression efficiency with the pSG5-NICD I performed Western blot 
analyses using antibodies against the NICD domain and against the Flag-tag, respectively 
(Fig. 23). Both antibodies detect a protein with the protein size of approximately 72kDa 
indicating a high expression of the active form of the Notch receptor 1 intracellular 
domain. The GapDH protein expression verifies the equal amounts of protein in both 
samples, the NICD overexpression and the mock control. Furthermore, I determined the 
expression of Hes1, a typical Notch signaling target gene (Fig. 24) to verify the influence 
of the enhanced Notch pathway activity on the cellular transcription potential. Using RT-
PCR analyses I could detect an induction of the Hes1 mRNA upon expression of  NICD 
compared to the mock control. 
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Fig. 23: Protein detection of the overexpressed NICD domain 
After transient expression of the NICD domain the transfection efficiency was verified using Western blot 
analyses. Both antibodies, the antibody against the Notch1 intracellular domain (NICD-V) and the antibody 
against the Flag tag strongly detected a protein band at 72kDa, which was absent in the protein lysate of the 
mock control. A specific antibody against GapDH (37kDa) verified similar loading amounts. 
 
Fig. 24: Hes1 mRNA detection 
Semi-quantitative RT-PCR shows the upregulation of the Hes1 mRNA upon NICD overexpression 
(ethidium bromide-stained band at 427bp). The RNA quantity is verified using primers for GapDH mRNA 
detection (204bp). 
Since this pathway needs cell-to-cell contact, I further wanted to test, if different cell 
densities might influence the basal and inducible Notch activity in SGHPL-5 cells. Fig. 25 
shows similar luciferase activities in a low-density cell population (60%, light grey bars) 
and high density cell population (95%, black bars) indicating that, at least in these ranges, 
the cell density does not influence the Notch activity. 
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Fig. 25: Notch activity in low cell density and high cell density cultures 
Using two different cell densities (60%, light gray bars; 95%, black bars) the luciferase activities were 
measured after transient transfection with mtCBFLuc, wtCBFLuc, NICDmock and NICD. As expected, the 
SGHPL-5 cells had an endogenous Notch activity, which could be further, induced upon NICD transfection, 
both independent of the cell density. Mean values ± SD of three experiments performed in duplicates are 
shown. Normalized value of unstimulated control (4xmtCBFLuc) was arbitrarily set at 100%. ***, P < 
0.001 
3.2.2. Notch pathway activity between SGHPL-5 cells and decidual 
fibroblasts 
Since in vivo the extravillous trophoblasts do have contact to decidual fibroblasts I 
wanted to figure out, if the trophoblastic cell line SGHPL-5 might communicate with first 
trimester decidual fibroblasts via the Notch pathway. Therefore, I used a modified 
transfection approach illustrated and described in materials and methods (Fig. 40).  
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Fig. 26: Stimulation of the Notch signaling with decidual fibroblasts 
The white bars represent the usage of the mutated CBF binding site (4xmtCBFLuc), the black bars show the 
transfection with the wild type CBF binding site (4xwtCBFLuc). The luciferase activity was enhanced in 
the presence of conditioned medium (endogenous Notch activity). In the presence of decidual fibroblasts, 
the Notch activity was further increased being reduced by DAPT. Mean values ± SD of three experiments 
performed in duplicates are shown. Normalized value of unstimulated control (4xmtCBFLuc) was 
arbitrarily set at 100%. *, P < 0.05 
Briefly, SGHPL-5 cells were transiently transfected with 4xwtCBFLuc und 4xmtCBFLuc 
for 6 hours and then stimulated with decidual fibroblasts or conditioned medium. The 
black bars represent the wild type CBF1 binding site; the white bars are used to show the 
basic levels of the luciferase activity (mutant CBF1 binding site). Fig 26 shows a 2fold 
induction of the luciferase activity in SGHPL-5 cells in the presence of conditioned 
medium. The same results were obtained in previous transfection experiments with 
normal cell culture medium suggesting, that the conditioned medium had no effect on the 
Notch activity. This result confirms that soluble factors in the conditioned medium could 
not stimulate the Notch communication among SGH-PL5 cells. The addition of 
fibroblasts strongly increased the luciferase activity compared to the medium control. The 
presence of the γ-Secretase inhibitor DAPT reduced the Notch activity to the base levels. 
The addition of fibroblasts did not stimulate the mutant CBF binding site verifying the 
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specificity of the experiments. This assay showed, that the decidual fibroblasts were able 
to stimulate the Notch pathway in the trophoblastic cell line. Furthermore, the physical 
contact was essential since the influence of secreted fibroblast specific factors on the 
endogenous Notch activity among the SGHPL-5 cells could be excluded. 
3.3. Notch signaling and migration 
Finally, I wanted to verify, if the Notch signaling has an effect on the migratory behaviour 
of the trophoblastic cell line SGHPL-5 and explant-derived EVTs. In both experimental 
approaches I used different concentrations of the γ-Secretase inhibitor DAPT to turn off 
endogenous Notch signaling. 
3.3.1. The inhibition of the Notch signaling stimulates the migration of 
SGHPL-5 
To test the migratory behaviour of SGHPL-5, I used a transwell assay system and 
performed the experiments with 0, 1, 10 or 100µM DAPT, respectively. After 24h, an 
increase of migration could be observed upon downregulation of the Notch signaling 
pathway in a dose-dependent manner (Fig. 27). Statistical significant results were 
obtained with 10µM and 100µM DAPT.  
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Fig. 27: Increase of migration upon downregulation of the Notch signaling in SGHPL-5 cells 
After 24h of migration, rising concentrations of DAPT caused an increase in the migratory behaviour of the 
trophoblastic cell line compared to the control (DMSO). Mean values ± SD of three experiments performed 
in triplicates are shown. Normalized value of unstimulated mock control was arbitrarily set at 100%. ns, not 
significant; *, P < 0.05 
3.3.2. The inhibition of the Notch signaling stimulates the migration of 
explant-derived EVTs 
Since the inhibition of the Notch cascade provoked an increase of migration, I wanted to 
verify, if primary cells do react similarly. For this purpose, I prepared villous explants 
cultures on rat-tail collagen I droplets and treated the organ cultures with 0.1, 1 and 10µM 
DAPT. In the first two concentrations, an increase of EVT migration was clearly 
detectable. The 10µM concentration had a toxic effect (data not shown) and was omitted 
for further studies. I used 12 explants each condition and repeated the experiment three 
times. All explants were monitored and photographed directly after seeding (0h), after 
24h and 48h. A representative sample is shown in figure 28A. Already after 24h the first 
differences could be observed. Turning off the Notch pathway leads to an enhanced EVT 
migration. After 48h, the EVTs reached a higher distance. Additionally, pictures at a 
higher magnification of the EVT population after 48h display a slightly different 
 Results 
 
 41 
phenotype. In the presence of 1µM DAPT the EVTs seem to achieve a more migratory 
phenotype having an elongated shape and a more loosened structure proximal to the cell 
column compared to the mock control EVTs. 
 
To objectively verify the outgrowth differences, I measured the distance that the EVTs 
had covered. For this purpose, I paced three arrows on each explant sample beginning at 
the villous tip and ending at the most distal EVT. The average distance of the EVTs was 
then calculated for each condition. The plot with the results is shown in Fig. 28B and 
confirms the previous findings. With rising concentrations of DAPT the migration of 
EVTs increases up to 1.8 fold in the presence of 1µM of the γ-Secretase inhibitor.  
Similar to the results obtained with the trophoblastic cell line SGHPL-5, the primary 
EVTs have an enhanced migratory behaviour upon downregulation of the Notch signaling 
activity. 
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Fig. 28A: Increased migration of explant-derived EVTs in the presence of DAPT 
Explants seeded on collagen were untreated or treated with 1µM DAPT were monitored and photographed 
at 0h, 24h and 48h. After 24 and 48h an enhanced EVT outgrowth could be observed. Higher 
magnifications after 48h shows also differences in the morphology of the EVT population to a more 
migratory phenotype compared to the mock control.  
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Fig. 28B: Rising concentrations of DAPT increase EVT migration 
After 48h of incubation the EVT outgrowth was verified. In the presence of 0.1µM and 1µM DAPT 
migration was significantly enhanced 1.5 and 1.8 fold, respectively. The distance represents the most distal 
EVTs and is measured in µm from the villous tissue. Mean values ± SD of three experiments performed with 
12 explants each condition are shown. ***, P < 0.001 
3.4. Coculture experiments of EVTs and decidual fibroblasts 
Finally, I performed coculture experiments using isolated decidual fibroblasts and 
explant-derived extravillous trophoblasts. The aim was to test behaviour of EVTs when 
reaching the fibroblast layer and further to verify the expression of Notch2 since this 
receptor was expressed in distal EVTs. Fig. 29 shows phase contrast pictures of the 
coculture system (df=decidual fibroblasts, evt=extravillous trophoblasts). Picture A 
displays the fibroblast layer (df) with a part of the villous tissue with the outgrowing 
extravillous trophoblasts (evt) nearly reaching the end of the collagen. Figure B shows the 
border, where the EVT population starts to contact the fibroblasts. Picture C and D finally 
show the EVTs overgrowing the fibroblasts. 
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Fig. 29: Coculture system between EVTs and decidual fibroblasts 
Picture A displays a 40 fold magnification of the fibroblast layer with the villous tissue on top of the 
collagen matrix with the outgrowing EVTs toward the fibroblasts. Higher magnifications of the contact 
points are shown in figures B-C. 
The cocultures were stained with specific markers in order to identify the different cell 
types. The left picture of the first panel (Fig. 30) displays the co-staining with 
cytokeratin7 (EVTs, green) and vimentin (fibroblasts, red). The EVTs have got into 
contact with the decidual fibroblasts. The right picture shows the co-staining with α5β1 
integrin (EVTs, green) together with vimentin (fibroblasts, red). The fibronectin receptor 
α5β1 is a marker for non-proliferative EVTs and clearly identifies this cell population in 
the coculture system. In the second and third row of pictures co-staining with Notch-2 and 
vimentin was performed. The pictures are taken at a 1000f magnification and show three 
cells, two are vimentin positive (red) and one has a strong Notch-2 expression (green). 
The Notch-2 positive cell is supposed to be an extravillous trophoblast since it lacks 
vimentin expression. This experiment has two interesting outcomes. First, the positive 
staining for Notch-2 in those differentiated EVT verifies the immunohistochemically 
obtained data; secondly, the fact that the in vitro grown EVTs express the same Notch 
receptor compared to the in vivo situation supports the idea that this model system might 
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mimic the in vivo situation correctly. However, the coculture system might be a helpful 
tool to study the Notch signaling not only in EVTs but also in decidual fibroblasts, which 
could give more insights into the communication and interaction between these two 
different cell types. 
Cyto7/Vim α5β1/Vim
Notch-2 DAPI
Notch-2/Vim Notch-2/Vim/Dapi
 
Fig. 30: Immunocytochemistry of cocultures of decidual fibroblasts and EVTs 
The first row of pictures is photographed at a 100f magnification; the left picture shows the border between 
EVTs (green, cytokeratin7) and decidual fibroblasts (red, vimentin), the right picture represents the EVT 
expression of α5β1 integrin (green) in the coculture system with fibroblasts (red, vimentin); The second and 
third panels show the expression of Notch-2 in EVTs (green), the corresponding nuclei staining in blue and 
the overlay pictures. Note, that Notch-2 is strongly expressed in the cell, that has no vimentin expression 
and is therefore supposed to be an EVT 
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4. Discussion 
The Notch signaling pathway plays important roles in cell biology such as cell 
proliferation, differentiation and apoptosis. Since there is very little known about the 
Notch pathway in the human placenta, this work is focused on the expression profiles, 
activity studies and functional experiments.  
4.1. Expression of the Notch receptors and ligands 
The immunohistochemical expression of Notch receptors and ligands are summarized in 
Fig. 31. Regarding the expression of Notch family members in the human placenta, only 
little information could be excerpted from literature. Cobellis and others have shown 
expression data of Notch1, Notch4 and Jagged-1 in human preeclamptic and age matched 
healthy term placentas finding a wide-spread appearance of all three members in the 
placental cell types with changes in preeclamptic samples (Cobellis et al., 2007; De Falco 
et al., 2007). The RT-PCR data (Fig. 10) have first revealed the occurrence of nearly all 
Notch receptors and ligands in the examined tissue and cell preparations. In the next 
paragraph I want to discuss the expression match between the RT-PCR and 
immunohistochemistry data since some of them seem to be slightly discordant. 
 
Notch Receptor 1: The mRNA of Notch1 (Fig. 10) is strongly detected in first trimester 
cytotrophoblasts (1stCTBs), weaker in 3rd trimester cytotrophoblasts and can be found in 
villous fibroblasts and the total tissue preparations of the first and third trimester and to 
some extent in the SGHPL-5 cells. The immunohistochemical detection was restricted to 
the trophoblasts of the proximal cell column (Fig. 11) and to the villous stroma (Fig. 12). 
This difference between the 1stCTBs and cell column expression between mRNA and 
protein could be possibly explained by the seeding method of 1st trimester CTBs. After 
trophoblast isolation, the cells are seeded on an extracellular matrix (MatrigelR) that 
rapidly induces the differentiation of the CTBs to EVTs. Although the mRNA of 1stCTBs 
is isolated already 16h after seeding, this incubation time could be enough for the 
beginning differentiation into EVTs thereby gaining some characteristics of the proximal 
cell column trophoblasts that show a strong Notch1 protein expression. However, the 
staining of proliferative and differentiated cells on parallel slides could show that the 
expression of this particular receptor does not correlate with the cell cycle. Hence, the 
upregulation of the receptor in this particular area could have a function in cell column 
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formation. The question which signal or intrinsic program initiates cell column formation 
still remains to be elucidated. Two putative theories of bipolar CTBs or differently 
committed CTBs have been compiled (Baczyk et al., 2006; James et al., 2005). Regarding 
the Notch-1 expression profile, Notch signaling might be involved in the determination 
towards cell column formation. The villous stromal expression of Notch1 protein is 
reflected by the mRNA expression of villous fibroblasts and is also reported by others 
(De Falco et al., 2007) but the total lack of Notch1 in the villous vessels and their 
surrounding muscle cells (Fig. 12) was not described by others and needs to be further 
elucidated. 
 
Notch Receptor 2: The mRNA of Notch2 (Fig. 10) could be found in all placental cell 
types and tissue preparations except the villous fibroblasts. This expression profile is 
reflected by the immunohistochemical data (Fig. 13) but the Notch2 protein was also 
expressed in villous stromal cells suggesting that the isolated fibroblasts somehow lost the 
requirement for Notch2 in culture. A damage of the Notch2 RNA could also be a reason 
for the lack of mRNA detection in PCR analyses. Additionally, Notch-2 was the only 
Notch receptor that could be found in the syncytiotrophoblast layer. However, the 
localisation of Notch2 was not regulated in any way regardless of the cell type and 
differentiation state. Interestingly, the trophoblastic cell line had a strong mRNA 
expression of Notch2 concluding that this cell line predominantly uses this particular 
receptor during Notch signaling. 
 
Notch Receptor 3: The mRNA of Notch3 (Fig. 10) was only found in 1st and 3rd 
trimester cytotrophoblasts. The staining pattern produced a slightly different pattern. The 
Notch3 protein was detected in villous stromal cells with a strong staining of villous 
vessels, their surrounding muscle cells and foetal blood cells (Fig. 14). Additionally, the 
protein was found in cytotrophoblasts and cell column trophoblasts with a decline along 
with the distance from the villous tip. Once more, the extraction possibilities of cDNA 
pools for the mRNA detection limit the consistence of RNA and protein data. The 
proximal part of the cell columns can hardly be isolated but might at least be partially 
reflected by the 1st CTBs that seems to be a mixture between 1st cytotrophoblasts and 
proximal cell column trophoblasts (EVT population) due to the seeding feasibility. 
Therefore, the mRNA signal in 1st CTBs comes from both, the CTBs and proximal EVTs. 
The EVT pool used for RT-PCR is gained after the culture of villous explants and reflects 
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very distal EVTs that are fully differentiated. This might explain, why there was no 
Notch1 and Notch3 mRNA expression in this particular cell population. The lack of any 
mRNA signal in villous fibroblasts could be again explained be the loss of receptor 
expression due to the culture conditions. Damaged RNA in the fibroblast pool could also 
be a reason for failed Notch3 mRNA expression. 
Notch Receptor 4: The mRNA of Notch4 (Fig. 10) could be found in 1st CTBs, tissue 
preparations of 1st and 3rd trimester, in villi obtained from explants and very weakly in 
3rd trimester CTBs. This finding correlates to the expression of the Notch4 protein (Fig. 
15) that was detected weakly in villous CTBs and very strongly in villous endothelial 
cells and foetal blood cells. 
 
Jagged-1: The mRNA of Jagged-1 (Fig. 10) could be found in all placental cell types and 
tissue preparations except the decidual fibroblasts. The protein expression and localisation 
(Fig.16) shows a similar pattern with an interesting protein expression profile in 
syncytiotrophoblasts (Fig. 17). The Jagged-1 protein could be detected in CTBs and cell 
column EVTs with a decrease along with the distance to the villous. Furthermore, those 
syncytia that had contact points to other syncytial layers had a very strong Jagged-1 
protein expression at the apical surface. This unprecedented staining pattern offers room 
for many speculations including a regulatory role in the syncytialisation process, the 
communication between syncytiotrophoblasts of different villi and possible mechanisms 
for repair machineries. The placental architecture has, similar to colon villi, the 
advantage, providing an enormous large surface important for the exchange of nutrients 
and gases between the mother and the foetus. The regulated expression of Jagged-1 could 
therefore be a mechanism to maintain the villous structure by inhibiting auto-fusion of 
different syncytial layers with each other since this would result in the reduction of 
surface area leading finally to a reduced exchange rates and malnutrition of the foetus. In 
fact, researchers of another field found out that Jagged-1 transduced stroma strongly 
inhibited the fusion of mononucleated myoblasts into multinucleated myotubes (Jaleco et 
al., 2001). The signaling could then presumably be transduced by Notch-2 since this 
receptor is the only one expressed in the syncytial epithelium. However, this finding 
should be further investigated regarding the intracellular domain of Notch2 and the Notch 
activity in syncytial layers that have contact to each other. 
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Jagged-2: The mRNA of Jagged-2 (Fig. 10) could be found in 1st and 3rd CTBs, in the 
tissue preparations and firstly, it was strongly expressed in EVT derived from villous 
explants that represent the most distal, non-proliferative and fully differentiated 
proportion of this cell type. Furthermore, compared to all the other Jagged-2 mRNA 
expression profiles, these cells expressed the mRNA of both splice variants in equal 
amounts suggesting that it might play a distinct role in distal EVTs. The mRNA 
expression correlated strongly with the protein expression and localisation (Fig. 18). 
Interestingly, the protein expression pattern changed from a uniform membranous 
staining found in the proximal cell column EVTs to a patchy but strong perinuclear 
expression profile in distal EVTs supporting the idea that the latter reflects the second 
splice variant found in mRNA studies. However, the expression of this ligand might play 
a role in the communication between decidual cells and trophoblasts since the mRNA and 
protein was expressed in distal EVTs and, additionally, seems to be differentially 
regulated. 
 
DLL-1: The mRNA of DLL-1 (Fig. 10) could only be found in 1st and weakly in 3rd CTBs 
and in the villous tissues of explant cultures. The protein expression profile shows a fully 
different expression profile suggesting that the RT-PCR should be improved for this 
particular ligand. The protein was expressed throughout the placenta with a weaker 
expression in syncytiotrophoblasts and distal EVTs (Fig.19). 
 
DLL-3: The mRNA of DLL-3 (Fig. 10) was nearly not detectable at all but the 
immunohistochemical protein detection revealed the DLL-3 protein expression on the 
apical surface of the syncytiotrophoblast layer and very distal EVTs. Similar to the RT-
PCR data obtained for DLL-1, the conditions for DLL-3 RT-PCR should also be 
improved. This ligand was the first, that shows some correlation to the EVT cell cycle 
exit since the areas of EVTs that express the ligand do overlap with the EVT parts that are 
widely negative for KI67 (proliferative cells) and positive for Kip2p57 (differentiated 
cells) (Fig. 20). 
 
DLL-4: The mRNA of DLL-4 (Fig. 10) was found in 1st and 3rd CTBs, decidual 
fibroblasts and the tissue preparations. These results perfectly correlate with the 
immunohistochemically obtained protein expression pattern where DLL-4 was expressed 
in villous stromal cells, cytotrophoblasts and the cell column EVTs with a decline along 
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with the distance from the villous tip (Fig. 21). The DLL-4 mRNA was absent in villous 
fibroblasts which could be explained be the different behaviour of cells in vivo and in 
vitro. Beside Notch-2, the ligand DLL-4 was the only one, whose mRNA was expressed 
in decidual fibroblast. I do not have any protein expression data of decidual cells since 
those are not present in the tissue pools of the first trimester placentae. However, these 
two Notch members might play a role in distal EVTs and decidual cells suggesting the 
investigation of Notch-2 and DLL-4 in coculture models with decidual cells and EVTs. 
 
Figure 29 shows a summary of the protein expression profile of the four Notch receptors 
and five Notch ligands. Regarding this summary Notch receptors are largely expressed in 
the proximal part of the placenta and could therefore play a role within the trophoblast 
population hence regulating the differentiation and invasion processes. However, the 
ligands have a steady expression all over the placenta supporting the idea that these could 
also be responsible for the communication and interaction with uterine cell types. Notch-2 
and DLL-1 were expressed in all cell types with no regulatory expression changes. Notch-
3, Jagged-1, Jagged-2 and DLL-4 were expressed in villous stromal cells, in 
cytotrophoblasts and cell column extravillous trophoblasts with an expression decline 
along with the distance to the villous tip. Notch-1 protein expression was only expressed 
in the proximal first few rows of cell column EVTs and the villous stroma, Notch-4 had a 
weak cytotrophoblast and a strong endothelial expression, which was also found by others 
(Uyttendaele et al., 1996) and DLL-3 showed expression in syncytium and distal EVTs. 
 
Taken together, one of the most promising receptors in this expression profile seems to be 
Notch-1 suggesting a regulatory role in cell column formation and/or maintenance of the 
EVT progenitor pool. Among the ligands, Jagged-1 is upregulated in contact sites of 
syncytial surfaces supporting the idea that it could influence syncytialization processes. 
Finally, the ligands Jagged-2 and DLL-3 show an enhanced expression in distal EVTs 
thereby potentially displaying a possibility of interaction between foetal EVTs and 
maternal decidual cell. Along their invasion into the maternal decidua and myometrium 
the EVTs get in contact with many different cell types including decidual fibroblasts, 
vessel associated smooth muscle cells, endothelial cells of spiral arteries, natural killer 
cells and others. The communication with each cell type might have different effects on 
the EVT behaviour and vice versa. The contact and communication between decidual 
fibroblast and EVTs, for example, could control the invasive depth of trophoblasts. 
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Enhanced trophoblast invasion is associated with pregnancy disorders including partial 
and complete mole placentae and chorion carcinomas. On the other hand, the reduced 
trophoblast invasion would result in pregnancy complications such as pre-eclampsia (Fig. 
4) and IUGR. 
It is also well known, that EVTs lead to vascular remodelling of the maternal spiral 
arteries by eliciting apoptosis in smooth muscle cells and endothelial cells (Ashton et al., 
2005; Cartwright et al., 2002). This process that could also be supported by signaling via 
the Notch cascade since Notch induces apoptosis in neural progenitor cells (Yang et al., 
2004). Summarizing the expression data, the multiplicity and locally restricted expression 
of the Notch receptors and ligands in the human placenta supports the idea that among 
others, Notch activity might play an important role in placental differentiation and 
regulatory processes that provides physiological adaptation of the placenta to the foetus’ 
demand along the pregnancy.  
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Fig. 31: Overview of the Notch receptor and ligand expression profile 
The CTBs express Notch2, Notch3, Jagged-1, Jagged-2, DLL-1 and DLL-4. Syncytiotrophoblasts express 
Notch2, Jagged-1, DLL-1 and DLL3; Villous stroma has all members except Notch4 and DLL-3; Fetal 
endothelial cells do not have Notch1 and DLL-3; Proximal cell column trophoblasts display all factors 
except Notch 4 and DLL-3 and distally, only Notch-2, Jagged-2, DLL-1 and DLL-3 are expressed 
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4.2. The Notch cascade activity in SGHPL-5 
Transfection experiments using the extravillous trophoblastic cell line SGHPL-5 gave 
some insights into the Notch activity of this particular cell line. Fig. 32 gives an overview 
of the Notch pathway and the used tools to perform Notch activity experiments. 
 
Two facts have proven the endogenous Notch signaling occurring between trophoblastic 
cells. First, the 2 fold induction of the luciferase activity of the wild type CBF1 Luciferase 
vector compared to the mutated CBF1 luciferase vector and, secondly, the reduction of 
the luciferase activity to basal levels using the γ-Secretase inhibitor DAPT (Fig. 22). The 
inhibitor specifically blocks the γ-Secretase activity whereupon the Notch intracellular 
domain cannot be cleaved from the cytoplasmic membrane and Notch signaling is 
inhibited. Furthermore, overexpression of the NICD resulted in another 2.5 fold increase 
of luciferase activity demonstrating that the endogenous Notch activity has not reached 
the top levels and can be further induced by exogenous stimuli.  
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Fig. 32: Schematic display of used tools in Notch activity 
The 4wtCBF1Luciferase and 4mtCBF1Luciferase vectors carrying 4 copies of the CBF1 binding site have 
been used to detect endogenous Notch activity. γ-Secretase inhibitor DAPT blocked cleavage of the Notch 
intracellular domain from the cytoplasmic membrane thereby blocking Notch signaling. NICD 
overexpression induced Notch signaling and Hes1 oligos were used to detect the Notch target gene 
expression. 
In control experiments, the specificity of the overexpressed NICD was verified using 
specific antibodies against the NICD-V (valine-cleaved Notch Intracellular Domain) and 
against the Flag tag (Fig. 23) confirming that the enhanced luciferase activity is 
stimulated by NICD overexpression. Furthermore, enhanced expression of Hes1 mRNA 
(Fig. 24) finally proved not only the activated Notch signaling due to transfected vectors 
but also revealed the cellular reactions due to the NICD stimulus. Final experiments with 
different cell densities confirmed that the confluence of the cells does not influence Notch 
activity at least in the range of 60-95% of confluency. 
 
These experiments using the extravillous trophoblastic cell line confirmed Notch activity 
in trophoblasts and support the idea that extravillous trophoblasts in vivo could exhibit a 
similar behaviour. Comparing the Notch receptor and ligand mRNA expression profile of 
the SGHPL-5 cells with CTBs suggests that there is a high communication potential 
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present that possibly controls a diversity of regulatory mechanisms in primary 
trophoblasts. 
 
In the next step I tested the ability of a different cell type to stimulate this particular 
pathway. Since EVTs contact decidual cells during the invasion process, I used 
fibroblasts isolated from maternal decidua in combination with SGHPL-5 and observed, 
that these cells were also able to stimulate Notch activity in trophoblast cells up to 2 fold 
measured from the endogenous activity level. This value nearly reached the luciferase 
activity levels obtained after overexpression of the NICD suggesting that decidual 
fibroblasts could provoke a maximal stimulation of Notch activity.  
 
These data gave some insights into the communication between trophoblasts and 
fibroblasts strongly supporting the idea that EVTs might cross-talk with decidual 
fibroblasts via the Notch signaling pathway. Considering the expression data of the Notch 
members in EVTs, only Notch-2 could be responsible for eliciting Notch activity in 
EVTs. With respect to the expression profile of the ligands in EVTs, it is possible that 
EVTs might activate the Notch signaling in decidual cells (Fig. 33). This could control 
proliferation and/or differentiation of decidual cells. Alternatively, activation of Notch 
activity could stimulate decidual fibroblasts to produce factors that in turn influence EVT 
invasion and differentiation. To confirm these speculations, transfection experiments of 
fibroblasts with a subsequent stimulation with EVTs should be performed. Furthermore, 
several receptors should be knocked out to verify if there are some candidates with unique 
regulatory features controlling EVT differentiation and invasion.  
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Fig. 33: Model for the interaction between EVTs and decidual fibroblasts 
The Model displays a possible communication way of the EVTs and decidual fibroblasts where the Notch 
signaling is induced in the fibroblast population by EVTs whereupon 2 possible effects are shown. First, 
EVT control decidual fibroblast proliferation and/or differentiation. Second, decidual fibroblasts produce 
and secrete factors that influence the trophoblast invasion and differentiation 
4.3. Notch activity influences trophoblast motility 
In this set of experiments I tested the influence of the Notch signaling cascade on 
trophoblast function. First, I performed migration assays with the extravillous 
trophoblastic cell line SGHPL-5 in the presence or absence of rising concentrations of γ–
Secretase inhibitor DAPT. In fact, migration was induced upon inhibition of the Notch 
pathway in a dose-dependent manner suggesting that active Notch signaling has an anti-
migratory effect on SGHPL-5 cells. Further studies using explant cultures showed a 
similar effect although the dosis of DAPT had to be reduced. Regarding EVT outgrowth 
from day to day, the first difference was already visible at 24h after seeding the explants 
on top of the collagen I matrix. The outgrowth area has nearly doubled compared to the 
DMSO control explants. After 48h, the different migration distances were still clearly 
detectable. Not only the distance of EVTs from the villus tip was twice as big as in 
control explants but also the morphology of EVTs has changed to a more elongated, 
invasive shape. Additionally, the whole EVT population seems to have a loosened contact 
to each other. These data leaves room for many speculations since most of the data 
Discussion 
 
58 
obtained from literature report a pro-migratory phenotype upon Notch activation (Wang 
et al., 2006; Wang et al.). In contrast, the inhibition of Notch signaling leads to an 
increase of migration in my experiments. 
 
However, these contrary results could be explained by the fact that most of the other 
studies are performed with tumor cells and we do observe the behaviour in a 
physiological cell population that has strictly regulated invasive characteristics. The 
question which role the active Notch pathway might have in the placental tissue needs to 
be further adressed. Since downregulated Notch activity has a pro-migratory effect, the 
active Notch signaling might influence events that support the cell-to-cell contact or 
maintain proliferation in EVTs. 
4.4. Coculture experiments of EVTs and decidual fibroblasts 
Finally, I used culture conditions where a confluent layer of fibroblasts was confronted 
with villous explant-derived EVTs (Fig. 29, 30). Phase contrast microscopy showed that 
the differentiated EVTs left the collagen drop and migrated towards the fibroblasts 
thereby contacting them (Fig. 29). Immunocytochemical detection of cytokeratin and 
vimentin clearly distinguished between EVTs and decidual fibroblasts (Fig. 30). The 
staining against the α5β1 fibronectin receptor further proved the differentiation state of 
EVTs. 
 
Most promising for all future experiments is the combination of decidual fibroblasts and 
differentiated EVTs in vitro since this particular approach perfectly mimics the in vivo 
situation and could finally give some insights into their mutual influence. Further 
experimental approaches using smooth muscle cells or endothelial cells instead of 
fibroblasts could further clarify the questions how the EVTs might interact with those cell 
types thereby helping to clarify the mechanisms of spiral artery remodelling. 
 
Even more interestingly, Notch-2 detections revealed that vimentin negative cells were 
positive for Notch receptor 2. This finding verified that Notch-2 expression in vitro was 
similar to the one in vivo, which is important for all further in vitro experiment studying 
Notch communication between EVTs and fibroblasts or other cell types. Regarding PCR 
data (Fig. 10), DLL-4 seems to be expressed moderately in decidual fibroblasts and its 
expression should be tested in co-culture experiments. Further approaches using the γ-
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Secretase inhibitor DAPT should be performed to control EVT and fibroblast behaviour 
upon Notch cascade inhibition.  
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5. Future Aspects 
Since some of Notch proteins display a very promising expression pattern, an approach 
with floating explants and DAPT should be performed to gain some insights into the 
importance of individual receptors. The proliferation and differentiation behaviour should 
be investigated in detail by the means of cell column formation and EVT differentiation. 
Since some of the Notch members are also specifically expressed in the syncytial layer, 
syncytialization processes could be investigated with the help of two different methods 
(Leisser et al., 2006). The resyncytialisation after a denudation step of villous explants 
could be compared between DAPT treated and untreated floating explants. Additionally, 
isolated cytotrophoblasts tend to syncytialize under certain conditions, which could also 
be tested in the presence or absence of DAPT. Furthermore, the proliferation rate should 
be measured in villous explants and cell cultures in the presence and absence of the γ-
Secretase inhibitor. In contrast to the inhibition studies, experiments based on Notch 
activation using soluble or membrane bound ligands should be performed. The co-culture 
model system should be further developed using different cell types, including 
trophoblasts, fibroblasts, smooth muscle cells, endothelial cells and NK cells thereby 
testing the communication potential of different placental cell types. Transfection 
experiments using fibroblasts and their Notch cascade activation potential due to EVT 
addition should be analysed. Furthermore, knock down experiments targeting several 
receptors and ligands should be included to verify if there are some candidates with 
unique regulatory features controlling EVT differentiation and invasion. The Notch 
pathway may control the proliferation and differentiation of placental cell types in many 
ways supporting the idea of the importance of this particular pathway in human placental 
development and function. 
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6. Materials and Methods 
6.1. Cell Culture 
6.1.1. Tissue collection 
Placental tissues of uncomplicated early pregnancies (between 6th and 12th week of 
gestation) were obtained by evacuation from legal abortions, with the permission of the 
ethical committee of the Medical University of Vienna. Informed consent of patients was 
obtained. The tissue was washed with ice-cold PBS (phosphate buffered saline) and 
further processed according to the following experimental demands.  
6.1.2. Cell Culture of SGHPL-5 
The immortalized trophoblastic cell line SGHPL-5 exhibit features of EVTs and behave 
similarly as primary trophoblasts with respect to invasion and vascular remodelling 
(Cartwright et al., 2002; Harris et al., 2006). They were cultivated in DMEM/Ham’s F-12 
(1:1), supplemented with 10% foetal growth serum (FBS) and gentamycin, under 
standardized conditions in a humidified chamber at 37°C, 5% CO2 and 21% O2 until they 
reached passage 15. Splitting of the cells were performed using 0.8ml 
0.25%Trypsin/EDTA per 10cm culture dish for 3min at 37°C. The reaction was stopped 
with culture medium. 
6.1.3. Purification and cultivation of first trimester cytotrophoblasts, 
villous and decidual fibroblasts 
Cytotrophoblasts of first trimester placentae were isolated by enzymatic digestion and 
density gradient centrifugation as described previously (Kliman et al., 1986; Knofler et 
al., 2004). Briefly, tissue was digested two times (30 min each) in Hanks′ balanced salt 
solution containing 25 mM HEPES, 0.125% trypsin and 250 IU/ml DNase I in a shaking 
water bath (37°C). After each digestion step, the supernatant was removed and 
neutralized with foetal bovine serum to a final concentration of 10%. The supernatants 
were pooled and filtered over a nylon sieve with the pore size of 80µm. Cells were then 
fractionated on a 5–70% discontinuous Percoll gradient. Trophoblast cells were isolated 
from the middle layer of the gradient (density of 1.048–1.062 g/ml). After centrifugation, 
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cells were immunopurified by depleting contaminating human leukocyte antigen (HLA)-I 
positive cells with anti-human HLA (clone W6/32; 0.2 µg/106 cells) conjugated to anti-
mouse immunoglobulin G (IgG) magnetic beads (Dynal, Oslo, Norway). Pure 
trophoblasts (>98% cytokeratin-7-positive cells) were seeded on rat-tail collagen I coated 
dishes at a density of 5 × 105 cells/cm2 and cultivated in DMEM/HamF12 containing 
10% FCS gold and gentamycin. 
Villous fibroblasts of different first trimester placentae were isolated after gradient 
centrifugation of trypsinized placental material (between 25% and 35% Percoll) and 
passaged two times in DMEM/HamF12 supplemented with 10% FCS gold and 
gentamycin. 
Decidual fibroblasts were gained by enzymatic digestion as described (Selam et al., 
2002). First trimester decidua was washed with ice-cold PBS and minced into 2mm3 
pieces. Digestion was performed in DMEM/HamF-12 containing 2mg/ml Collagenase I 
(484IU/ml) and 0,5mg/ml DNAse I. 10g of tissue per 10ml digestion solution was 
incubated in a shaking water bath at 37°C for 45 minutes. The reaction was stopped with 
10 % FBS and the supernatant was filtered through an 80mm nylon sieve to remove 
undigested material. A second digestion step was performed with the remaining tissue for 
another 30 minutes. Both supernatants were centrifuged for 10 minutes at 1500 rpm and 
cells were pooled. After two washing steps with 1x HANKS balanced solution the cells 
were resuspended with prewarmed DMEM/HamF12 (1:1) supplemented with 10%FBS 
gold and gentamycin, and cultivated under standard conditions. The following day, the 
cells were splitted and further cultivated until they reached passage 8. All experiments 
were performed between passage 3 to 5.  
6.1.4. First trimester villous explant culture 
Villous placental explants were grown in DMEM/HamF12 containing gentamycin unless 
otherwise noted. Placental tissues were processed as described elsewhere with minor 
modifications (Bauer et al., 2004; Genbacev et al., 1992; Vicovac et al., 1995). Villous 
pieces were cut under the stereo-microscope (20fold magnification) and put into pre-
warmed culture medium. The pieces were incubated at 37°C under standard culture 
conditions over night. On the next day villous explants were seeded on top of rat-tail 
collagen I (Fig. 30). After 4h, the villous explants were covered with serumfree culture 
medium and experiments were performed as described. 
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During the first 12-24h in culture, the cytotrophoblasts proliferate and form a cell column. 
Then, EVTs start to migrate on the surface of the collagen, which facilitates the 
monitoring of the migratory behaviour from day to day. Since the EVTs of the explant 
system undergo the same differentiation processes as they are observed from in vivo 
investigations (integrin switch, cell cycle exit), this cell culture model is a very useful tool 
to study the differentiation behaviour of the EVTs under different conditions. 
The collagen droplets were prepared as following: rat-tail collagen I was first gently 
mixed with 10xDMEM. The transparent colour of the collagen switched to light yellow. 
A 7.5% sodium bicarbonate solution was added and mixed carefully to avoid any air 
bubbles, the colour switched to pink. Droplets were placed in the centre of 24well plates 
and left for 30 minutes at 37°C to polymerise. The drops were flooded with 0.5 ml culture 
medium and left for another 10 minutes at 37°C. Next, the medium was removed, one 
explant was placed in the centre of each drop and proceeded as described above. For 
experiments with the DAPT [N-(3,5-difluorophenylacetyl-L-alanyl)]-S-phenylglycine t-
ButylEster] (Calbiochem), explants were covered with culture medium either with or 
without different concentrations of DAPT or with an appropriate amount of DMSO 
(vehicle for DAPT; mock control). The outgrowth of the EVTs was observed day by day 
and every explant was photographed with an Olympus inverse X71 microscope directly 
after seeding, after 24h and 48h. 
Placental villus
EVTs
Collagen I
 
Fig. 34: EVT outgrowth on rat tail collagen I 
Outgrowing extravillous trophoblasts proliferate and migrate on the surface of the collagen droplet thereby 
undergoing typical differentiation processes (integrin switch, cell cycle exit) 
Collage drops: 
1ml rat-tail collagen (3.7mg/ml) 
0.1ml 10xDMEM 
0.2ml 0.75% Sodium Bicarbonat solution 
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6.1.5. Coculture experiments of EVTs and decidual fibroblasts (Fig. 32) 
The coculture model was performed on the basis of a method published by Cohen and 
colleagues with some modifications (Cohen and Bischof, 2009). Decidual fibroblasts 
(passage3) were grown in a 100mm culture dish until they reached confluency. Then the 
cells were washed with prewarmed PBS and the solution was removed. 12 collagen drops 
(the protocol is described in the 5.1.4.) were placed onto the fibroblast layer and 
incubated in the incubation chamber for 30min. Afterwards, the fibroblasts were covered 
with medium leaving collagen drops dry. The explants were placed in the centre of each 
drop and left for 4h in the incubation chamber for the first attachment. Subsequently, the 
cultures plates were filled with culture medium until the explant tissues were fully 
covered. The outgrowth of the EVTs was controlled every day and after 72h, the plates 
were carefully washed three times with ice-cold PBS and further processed for 
immunocytochemistry. 
0h
24h
72h
 
Fig. 35: Coculture Model System 
The red cells (decidual fibroblasts, endothelial cells, smooth muscle cells or NK cells) form the confluent 
layer. The villous explants are seeded on top of the collagen drop and the EVTs (green) proliferate and 
migrate towards the cell layer until they have contact to the cells of the confluent layer. Subsequent staining 
with antibodies against the cleaved intracellular domain of the Notch members might confirm the active 
Notch signaling and the signal receiving cell. 
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6.1.6. Immunocytochemistry of 100mm culture dishes 
The coculture dishes of villous explants and fibroblasts were covered with 4% 
Paraformaldehyd/PBS for 15minat RT, followed by a permeabilization step with 0.1% 
TritonX-100/PBS for another 5min at RT. After 3 washing steps with ice-cold PBS, the 
villous tissues were carefully removed with forceps. The individual coculture areas were 
surrounded with an ImmEdgeTm pen (Vector) to define the staining areas and the staining 
was performed according to the protocol described in 2.7. After the counter stain with 
DAPI, each area was mounted with mounting medium and covered with suitable cover 
plates. The staining was analysed using an inverse microscope (Olympus IX71) and 
representative areas were digitally photographed. 
6.1.7. Migration assay 
Transwell migrations assays were performed using transwell inserts (8µm pore size, 
Costar) with SGHPL-5 cells. 50.000 cells were seeded in the presence or absence of 1, 10, 
or 100 µM DAPT or MOCK (DMSO) in culture medium. After 24 hours of incubation 
under standardized conditions, the cells were washed with prewarmed PBS and fixed with 
ice-cold methanol for 10 min at room temperature. After 3 washing steps with cold PBS 
the nuclei were stained with DAPI (4’,6-Diamidin-2’-phenylindoldihydrochlorid, 1:1000 
in PBS) for 10min at RT. The cells on the upper side of the inserts were removed with a 
cotton swap. The filters were excised and mounted in mounting medium for fluorescence 
microscopy. For evaluation, five areas per filter were digitally photographed and the 
number of migrated cells was evaluated using the Olympus Cell Imaging Software. 
6.2. RNA and Protein expression 
6.2.1. RNA extraction and semi-quantitative RT-PCR 
RNA and was extracted from frozen tissue samples (9.SSW, Villi and EVT) or cultured 
cells (cytotrophoblasts, villous and decidual fibroblasts, SGHPL-5) with TriFast Reagent 
(Peqlab) according to the manufacturer’s instructions. Villi and EVT were mechanically 
separated under the microscope and further processed. The tissue samples were first 
reduced to powder. Briefly, tissues were frozen in liquid nitrogen and homogenized in a 
microdismembrator at 2000rpm for 1,5min. The resulting powder was put into TriFast 
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and the RNA isolation protocol was further processed. Quantity and Quality of RNA was 
evaluated using the Nanodrop elisa. 1µg of total RNA was reverse transcribed in 20µl 
reaction volume using 1µl MMLVSuperScript and 0.4µl Hexanucleotide Mix (62.5 
A260U/ml) according to the manufacturer’s instructions. Semi-quantitative PCR 
amplification was performed with PCR Reagent System in a RoboCycler Gradient 96 
(Stratagene). Cycle numbers were optimized within the linear range of individual PCR 
reactions. Oligonucleotide primers, annealing temperatures, product sizes and cycle 
numbers are listed in table 3. In all experiments, possible DNA contamination was 
checked by negative control RT–PCR in which reverse transcriptase was omitted in the 
RT step. The PCR products were analysed on 1.5% agarose gels containing ethidium 
bromide and photographed under UV radiation. 
 
Name Sequence 5’ 3’ Start Tm °C Cycle # size, bp 
Notch-1 1s TAC AAG TGC AAC TGC CTG CT 2437 51 30 407 
Notch-1 1a TCG TTG ATC TCC TCC TCA CA 2843    
Notch-2 1s TGA ACA ACT GCT CCA GGA TG 4921 53 27 401 
Notch-2 1a TGA TGA CAA CAG CAA CAG CA 5321    
Notch-3 1s GCC TGC CTC TAC GAC AAC TT 4424 49 35 400 
Notch-3 1a TTA CTA CCG AGC CGA TCA CC 4823    
Notch-4 1s TGG ATG AGT GCC TGA GTG AC 1908 52 40 406 
Notch-4 1a GTG GGT CCT GTG TAG CCT GT 2313    
Jagged-1 1s GTG GCT TGG ATC TGT TGC TT 3751 50 27 395 
Jagged-1 1a CTC TGG GCA CTT TCC AAG TC 4145    
Jagged-2 1s ACA TCG ATG AGT GTG CTT CG 1558 55 30 302/190 
Jagged-2 1a CAC ACA CTG GTA CCC GTT CA 1859    
DLL-1 1s AGA CGG AGA CCA TGA ACA AC 2227 47 35 382 
DLL-1 1a TCC TCG GAT ATG ACG TAC AC 2608    
DLL-3 1s GAC CCT CAG CGC TAC CTT TT 1517 48 35 703/365 
DLL-3 1a CAC CAC CGA GCA AAT ACA AA 2219    
DLL-4 1s TGA CCA CTT CGG CCA CTA TG 896 50 40 620 
DLL-4 1a AGT TGG AGC CGG TGA AGT TG 1515    
Hes-1 1s GG CTG ATA ACA GCG GAA TC 22 52 27 427 
Hes-1 1a CGC GAG CTA TCT TTC TTC AG 448    
GapDH 1s CCA TGG AGA AGG CTG GGG 413 52 25 204 
GapDH 1a CAA AGT TGT CAT GGA TGA CC 607    
 Materials and Methods 
 
 69 
Table 2: Oligo sequences and PCR conditions 
Names of the primer nucleotides, the sequences, the start and end points on the different mRNAs, the 
Annealing temperature (Tm), the PCR cycle number and the cDNA fragment sizes in base pairs (bp) are 
listed in table 3. 
6.2.2. Western blot analyses 
For protein detections, equal concentrations (normalized to RNA amounts) were loaded 
on 8.5% polyacrylamide (PAA) gels and blotted onto nitrocellulose membrane  
For the detection of NICD expression the SGHPL-5 cells were lysed by freezing and 
thawing in the protein lyses buffer. The protein concentrations were verified by Bradford 
assay. 30µg protein lysate was mixed with 5xSDS-sample buffer, reduced with 1% β-
mercaptoethanol, heated for 5min at 98°C and separated on a 10% SDS-PAA Gel. The 
proteins were then blotted onto nitrocellulose membrane (Protran, Schleicher/Schüll) 
overnight in protein transfer buffer with constant 20mV. Staining of the proteins with 
Ponceau’S solution controlled blotting outcome. After blocking with 5% non-fat milk in 
TBS-T for 1h at room temperature, the membranes were incubated with rabbit anti-human 
cleaved Notch1 intracellular domain (cell signaling, 1:1000 in BSA/TBS-T), rabbit anti 
human Flag (cell signaling, 1:1000 in BSA/TBS-T) and rabbit anti-human GAPDH (cell 
signaling, 1:5000 in BSA/TBS-T) overnight at 4°C. After 3 washing steps with TBS-T, 
secondary antibodies (goat anti rabbit, 1:50000) were diluted in 0.5% non-fat milk/TBS-T 
and added to the membranes for 1hour at RT. The detection was performed with 
Enhanced Chemiluminescence System (Amersham Pharmacia Biotech) and signals were 
visualized on autoradiography films. 
 
Solutions: 
Protein Lyses Buffer 
20mM Hepes, pH 7.9 
1% TritonX-100 
0.4M NaCl 
2.5% Glycerol 
1mM EDTA 
1mM PMSF 
0.5mM DTT 
0.5% Protease Inhibitor Cocktail 
 
4xSeparating Gel Buffer, pH 8.8 
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1.5M Tris Base 
0.4% SDS 
 
4xStacking Gel Buffer, pH 6.8 
0.5M Tris Base 
0.4% SDS 
 
10xSDS Page running buffer 
0.4M Tris Base 
1.92M Glycine 
1% SDS 
 
Ponceau S 
0.5% Ponceau 
5% acetic acid 
 
10xTris-Buffered Saline (TBS), pH7.6 
0.2M Tris Base 
1,45M NaCl 
 
Tris-buffered Saline (TBS-T) 
1xTBS 
0.1% Tween20 
 
5x SDS sample buffer 
100mM Tris HCl, pH 6.8 
5% SDS 
25% Glycerol 
0.01% bromophenol blue 
 
Protein transfer buffer, pH 8.3 
25mM Tris Base 
192mM Glycine 
0.01% SDS 
20% MeOH 
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BSA/TBS-T 
5% BSA 
TBS-T 
6.2.3. Immunohistochemistry 
First trimester tissue was fixed in 4.5 % formalin for at least 4h and embedded in paraffin. 
Serial sections (3µm) of paraffin-embedded first trimester placental tissues were prepared 
with a microtome as previously described (Bauer et al., 2004; Pollheimer et al., 2006). 
Slides were dried for 15min at 56°C, dewaxed in xylol for 10min and slowly rehydrated 
in decreasing concentrations of ethanol until Aqua destillata (A.d.) was reached. The 
antigen retrieval was performed in a suitable chamber using a 0.5% citraconic anhydride 
solution and heating the slides in a water bath at 98°C for 20min. Next, the slides were 
left for 20min at RT to cool down and were then washed with PBS twice. Then the slides 
were clamped with plastic cover slips (shandon) and placed into the staining chamber 
(shandon). Using this technique, the slides are permanently covered with an 80µl liquid 
film that can be replaced easily by pipetting another solution on top of the sections; the 
changing is performed by gravity flow. The volume of blocking and staining solutions 
could be reduced to 100 µl. Unspecific antibody reactions were minimized using 0.05% 
fish skin/PBS for 30minutes. The primary antibodies were incubated over night at 4°C. 
Subsequently a washing step was were performed with 100mM TrisCl (pH7.5), 50mM 
NaCl, 0.05%Tween (=washing buffer) by filling the gap between the slides and the cover 
plates with approximately 3ml. The secondary antibodies were added for 1 hour at RT 
and after an additionally washing step, the counterstain of the nuclei was done with DAPI 
(1:1000) for 10 min at RT. Finally, the slides were removed from the staining chamber 
and the sections were embedded with fluorescence fitting mounting medium and suitable 
cover plates. All used primary and secondary antibodies and their dilutions are listed in 
table 4. The sections were analysed by fluorescence microscopy (Olympus, BX50) and 
representative areas were digitally photographed. 
 
Solutions: 
 
Washing Buffer 
0.1M TrisCl (pH7.5) 
0.15M NaCl 
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0.05% Tween20 
 
Antigen retrieval 
0.05% citraconic anhydride (pH 7 
10xPhosphate Buffered Saline (PBS), pH 7.4 
125mM Na2HPO4 
20mM KH2PO4 
1.4M NaCl 
 
Blocking buffer 
0.05% fish skin / PBS 
6.3. Transfection experiments 
6.3.1. Plasmid preparation 
The luciferase plasmids 4xwtCBFLuc-pGL2-Promoter (Fig. 32A) and 4xmtCBFLuc (Fig. 
32B) und the eukaryotic transient expression plasmid pSG5-Flag-NICD (Fig. 32C) were 
kind gifts of S. Diane Hayward. Both, the wild type and mutant CBF1 binding sites were 
cloned into pGL2-Promoter Vector via Bgl-II, respectively. The NICD domain was 
cloned into the eukaryotic expression vector pSG5 (Stratagene). Two negative controls 
for the NICD vector were obtained. First, the NICD domain was removed by digestion 
with BglII and BamH1. Second, the whole fragment including the Flag and polyA tail 
were excised using EcoR1 and Xba1. Since both controls showed similar effects in Notch 
signaling pathway stimulation in transfection studies, the EcoR1/XbaI generated negative 
control was used for all further studies. 
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4x 941/942 (wild type CBF1 site)
Bgl II
Bgl II
 
Fig. 36A: 4xwtCBFLuc 
Four copies of the wild type CBF1 binding site are cloned into a pGL2 promoter vector via the Bgl-II 
restriction site. 
4x 1110/1111 (mutant CBF1 site)
Bgl II
Bgl II
 
Fig. 36B: 4xmtCBFLuc 
Four copies of a mutated variant of the CBF1 binding site are cloned into the pGL-2 promoter vector via the 
Bgl-II restriction site 
NICD (1751-2294)
Bgl II/BamH1
Bgl II/BamH1
XbaI
EcoRI Flag
polyA
SG5-Flag-NICD
 
Fig. 36C: SG5-Flag-NICD 
The notch 1 intracellular domain is cloned into the eukaryotic transient expression vector pSG5 via Bgl-
II/BamH1; the mock control is generated excising the whole insert via EcoRI and XbaI. 
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6.3.2. Transfection of SGHPL-5 
For reporter studies, SGHPL-5 cells were transiently transfected using Lipofectamine 
(Stratagene; 2µl each well) as described by the supplier. 50.000 cells were seeded into 
each well of a 24well plate. After 24h, the culture medium was changed and the cells 
were transfected. The concentrations of the plasmids, different combinations and 
stimulations are listed in table 5. Two parallel transfections per condition were performed. 
The transfection mixture was added to the cells and left for 6h under standardized culture 
conditions. After the incubation period, the medium was replaced with fresh, prewarmed 
culture medium with or without 10µM DAPT was added. After another hour, further 
stimulating agents were substituted (see table 5). 
For stimulation with decidual fibroblasts (Fig. 33), I used SGHPL-5 (passage 7-9) and 
isolated decidual fibroblasts (passage 2-3). First, I prepared the transient transfection with 
the SGH-PL-5 cells according to the protocol described above. After 6h, I washed the 
cells and added the fibroblasts in two-fold excess to the SGHPL-5 cells. 
After 18h of incubation the cells were either treated with Tri-Fast reagent for RNA 
preparation, protein lyses buffer for western blot analyses or 5xreporter lyses buffer 
(promega) for β-Galactosidase assay and luciferase activity assay. 
 
Plasmids concentrations stimulations analyses 
4xwtCBF1Luc 
pCMV-β-Gal 
0.75µg/well 
0.25µg/well 
+/- 10µM DAPT 
+/- DMSO 
+/- decidual fibroblasts/ 
+/- conditioned medium 
β-Gal assay 
Luciferase assay 
4xmtCBF1Luc 
pCMV-β-Gal 
0.75µg/well 
0.25µg/well 
+/- 10µM DAPT 
+/ DMSO 
+/- decidual fibroblasts/ 
conditioned medium 
β-Gal assay 
Luciferase assay 
4xwtCBF1Luc 
pSG5-Flag-NICD 
pCMV-β-Gal 
0.75µg/well 
0.75µg/well 
0.25µg/well 
 β-Gal assay 
Luciferase assay 
4xwtCBF1Luc 
pSG5-Flag-mock 
pCMV-β-Gal 
0.75µg/well 
0.75µg/well 
0.25µg/well 
 β-Gal assay 
Luciferase assay 
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Plasmids concentrations stimulations analyses 
4xmtCBF1Luc 
pSG5-Flag-NICD 
pCMV-β-Gal 
0.75µg/well 
0.75µg/well 
0.25µg/well 
 β-Gal assay 
Luciferase assay 
4xmtCBF1Luc 
pSG5-Flag-mock 
pCMV-β-Gal 
0.75µg/well 
0.75µg/well 
0.25µg/well 
 β-Gal assay 
Luciferase assay 
pSG5-Flag-NICD 
pCMV-β-Gal 
0.75µg/well 
0.25µg/well 
 RT-PCR 
Western blot 
pSG5-Flag-mock 
pCMV-β-Gal 
0.75µg/well 
0.25µg/well 
 RT-PCR 
Western blot 
Table 3: different approaches used in transfection experiments  
The combinations and concentrations and the following analysis applications are given in table 4 
6h
+
18h
Luciferase activity
SGH-PL5
decidual fibroblasts
 
Fig. 37: Transient transfection of SGHPL-5 following stimulation with decidual fibroblasts 
The SGHPL-5 were transiently transfected with either 4wtCBFLuc of 4mtCBFLuc for 6h. Then, the cells 
were washed and decidual fibroblasts were added in a ration of 1:2; the coculture was left for another 18h. 
Finally the cells were harvested and the protein lysates were prepared for the measurement of luciferase 
activity displaying only the activity in SGHPL-5 cells. 
6.3.3. β-Galactosidase and Luciferase Activity Assay 
At the end of transfection, the cells were lysed using 100µl reporter lyses buffer 
(Promega) according to the manufacturer’s instructions. For β-Gal activity measurement, 
20µl of the protein sample were mixed with 200 µl chromogenic substrate chlorophenol 
Materials and Methods 
 
76 
red-β-D-galactopyranoside (CPRG) buffer and incubated until a clear colour change from 
yellow to orange was visible indicating the conversion of the CPRG reagent. The reaction 
was stopped with 1ml A.d. and the optical density was photometrically determined at 
570nm. 
The luciferase activity was determined on a luminometer using Luciferase Assay System 
(Promega) and 10µl protein extract. Both activity assays, β-Gal and luciferase, were 
measured in duplicates. 
 
Solutions: CPRG buffer 
  80mM NaPO4 
  18mM MgCl2 
   200mM β-Mercaptoethanol 
  16mM CPRG 
Name (anti-) Species Cat.# Company Dilution Application 
Cytokeratin 7 Mouse  Dako 1:100 IHC 
Vimentin Rabbit  Abcam 1:100 IHC 
KI67 Mouse  Chemicon 1:100 IHC 
Kip2p57 Rabbit  Santa Cruz 1:200 IHC 
Notch1 Rabbit 3608 Cell Signaling 1:150 IHC 
Notch2 Rabbit PAB1123 Abnova 1:150 IHC 
Notch3 Rabbit Sc-5593 Santa Cruz 1:150 IHC 
Notch4 Rabbit Sc-5594 Santa Cruz 1:40 IHC 
Jagged1 Rabbit Sc-8303 Santa Cruz 1:100 IHC 
Jagged2 Rabbit 2210 Cell Signaling 1:150 IHC 
DLL1 Rabbit Ab76655 Abcam 1:150 IHC 
DLL3 Rabbit Sc-67269 Santa Cruz 1:150 IHC 
DLL4 Rabbit PAB10200 Abnova 1:200 IHC 
NICD cleaved Rabbit  Cell signaling 1:1000 WB 
Flag Rabbit  Cell signaling 1:1000 WB 
GapDH Rabbit  Cell signaling 1:1000 WB 
Table 4: list of primary antibodies 
Immunohistochemistry (IHC), Western blot (WB) 
Name (anti-) Species Cat.# Company Dilution Application 
Alexa flour 488 Goat-anti-mouse  Mol. probes 1:1000 IHC 
Alexa fluor 488 Goat-anti-rabbit  Mol. probes 1:1000 IHC 
Alexa flour 568 Goat-anti-rabbit  Mol. probes 1:1000 IHC 
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Name (anti-) Species Cat.# Company Dilution Application 
HRP  Goat-anti-rabbit   1:50000 WB 
HRP Goat-anti-mouse   1:50000 WB 
Table 5: list of secondary antibodies 
Immunohistochemistry (IHC), Western blot (WB) 
6.4. Statistical analyses 
Statistical analyses were performed with Student’s t test. A P value < 0.05 was considered 
statistically significant 
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